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Abstract 
Human bone marrow multipotent mesenchymal stromal cells (hBM-MSC) represent an 
appealing source of adult stem cells for cell therapy and tissue engineering. Since hBM-MSC 
are present at low frequency in the bone marrow, in vitro expansion is necessary prior to 
performing clinical studies. Standard incubator gas tensions corresponding to 20% O2 and 5% 
CO2 are routinely used for in vitro expansion of hBM-MSC, and it is being overlooked that 
such conditions do not correspond to the physiological gas tensions found in the bone marrow 
microenvironment. To explore the effects of different gas tensions, polyclonal hBM-MSC 
from three donors were expanded in 6 different combinations of O2 and CO2 tensions. Phase 
contrast microscopy was used to determine cell morphological features, growth curves were 
made to assess differences in proliferative capability, real-time RT PCR was used to measure 
gene expression of markers associated with undifferentiated embryonic stem cells, and 
microarray analysis was performed to assess the global gene expression of the cells. No 
change in morphology could be observed between hBM-MSC cultured in the different gas 
tensions. The results from the growth curves indicated that gas tensions did not affect the 
proliferative capability of the cells. Real-time RT PCR data showed no consistent difference 
in gene expression between the culture conditions. According to the microarray analysis, there 
was no significant difference in global gene expression between hBM-MSC cultured in the 
different gas tensions.  
 
Most current protocols for in vitro culture of hBM-MSC include fetal bovine serum (FBS) as 
nutritional supplement. When culturing hBM-MSC in FBS, depletion of CD14+ monocytes 
seems to be necessary in order to avoid monocyte contamination in the cultures. In this study, 
FBS was replaced by autologous serum (AS). As a part of this thesis, the necessity of 
depleting CD14+ cells when expanding hBM-MSC in AS was investigated. Only minor 
contamination of monocytes was observed in the  non-depleted cultures, indicating that there 
is no need to deplete CD14+ cells when expanding hBM-MSC in AS.  
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1. Introduction 
1.1 Stem cells 
Over the past few years, stem cell research has received tremendous interest from scientists, 
because of its suggested potential to provide cures or new treatment modalities for numerous 
incurable diseases and injuries. Many questions about stem cells remain unanswered since the 
field of stem cell research is still in its early stages. Clearly, further research will provide 
some of these answers, but like any scientific field, stem cell research raises as many 
questions as it answers.  
 
A stem cell, by definition, is an undifferentiated (unspecialized) cell that can produce both 
new stem cells (self-renewal), and cells that commit to a pathway leading to differentiation1 
(Figure 1-1).  
 
 
Figure 1-1. A stem cell is an undifferentiated cell that has the ability to reproduce itself in a process called self-
renewal. It also can differentiate and give rise to specialized cells that make up tissues and organs of the body. In 
adult and fetal tissues, the daughter cells committed to differentiation first become precursor cells. These can 




Differentiation is a process where an unspecialized cell changes to acquire features typical of 
cells of one of the organs in the body. Stem cells remain uncommitted and in a slowly 
proliferating state in vivo, until they receive a signal to develop into a specialized cell2. This 
differentiation signal triggers altered expression of genes involved in cell division and 
differentiation. Depending on the signal provided, the cells can undergo both symmetric 
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division (identical daughter cells) and asymmetric division (non-identical daughter cells) in 
order to maintain or expand the stem cell pool and to produce differentiated progeny. Some 
stem cells can produce a variety of differentiated cells3, while other stem cells only generate a 
few, or one type differentiated cells. Stem cells in the testis, for example, produce only one 
type differentiated cells (the spermatozoa)4. 
 
1.2 Classification of stem cells 
1.2.1 Embryonic stem cells 
Animals start their life as a fertilized egg referred to as a zygote (figure 1-2). The zygote is 
totipotent5, meaning that it is capable of giving rise to all the cell types found in animals, 
including those that do not form part of the embryo, such as the cells of the placenta and 
umbilical cord. A complex cascade of gene regulation drives the zygote through several 
rounds of mitotic division called cleavage, resulting in gradually smaller cells. Between four 
and six days after fertilization the cells are arranged  into two regions, an outer layer called 
the trophectoderm (or trophoblast) which is involved in implantation and formation of the 
placenta, and an inner core of cells called the inner cell mass (ICM). At this stage the embryo 
is referred to as a blastocyst6, 7. During development the ICM develops into two distinct cell 
layers, the epiblast and hypoblast. The hypoblast gives rise to the yolk sac, and the epiblast 
gives rise to the three primary germ layers (ectoderm, endoderm, and mesoderm). The three 
germ layers further develop into all the cells and organs that make up the adult body (figure 1-
2). Another type of cells called primordial germ cells (PGC), which reside in a specific part of 
the embryo called the gonadal ridge, give rise to the germ cells (eggs and sperm). 
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Figure 1-2. Major types of cells differentiated from the germ layer cells (Reprinted from Stem cells: Scientific 
progress and future research directions – a stem cell report from The National Institutes of Health june 17, 2001, 
with permission from Terese Winslow). 
 
Embryonic stem cells (ESC) are derived by removing the ICM from the blastocyst, and 
growing the cells in vitro in a laboratory culture dish (figure 1-3). These cells are 
undifferentiated, they can proliferate indefinitely in culture, and they are capable of giving 
rise to all the cells in the adult body3, 8. Cells with this capability are said to be pluripotent. 
The difference between the totipotent zygote and the pluripotent ESC, is that the ESC can 
only generate cells that form part of the embryo, and lack the ability of the zygote to form 
extraembryonic tissues8. 
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Figure 1-3. Derivation of human ESC. 
Approximately five days after in vitro fertilization a 
blastocyst develops. ESC (pluripotent stem cells) 
are derived by removing the ICM from the 
blastocyst, and culturing the cells in vitro. 
(Reprinted from Regenerative medicine 2006 - a 
stem cell report from The National Institutes of 
Health, with permission from Terese Winslow). 
 
 
Several proteins play a central role in directing self-renewal and maintaining pluripotency of 
ESC. Among these are the transcription factors Oct-49, Nanog10, Sox211, c-Myc 12 and Klf-
410. Recently, Takahashi et al. demonstrated that pluripotency in mouse embryonic and adult 
fibroblasts was induced by introducing Oct-4, Sox2, c-Myc and Klf-4, under ESC culture 
conditions13. These transcription factors activate transcription of genes that are essential for 
pluripotency and suppress genes that are responsible for differentiation. The regulation of 
these transcription factors and the mechanism by which they work to maintain pluripotency 
are not fully understood.  
 
1.2.2 Adult stem cells 
Most, if not all, adult organs in the body contain stem cells, which are referred to as adult 
stem cells (ASC). These cells have a more restricted differentiation potential compared to the 
ESC, and lack the capability of the ESC of unlimited proliferation in culture. Stem cells with 
limited differentiation potential are often called multipotent stem cells. Originally, it was 
thought that ASC could only differentiate into the cell types of the organ/tissue from which 
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they originated. However, more recent studies  have described differentiation of ASC into 
mature phenotypes that are different from their organ/tissue of origin14, 15, leaving this topic 
controversial16. 
 
Throughout life, billions of dead cells are replaced by new cells every day in order to maintain 
tissue homeostasis. The main function of the ASC is to regenerate and repair the tissues in 
which they reside. Normally, ASC produce progenitor cells, which proliferate before they 
differentiate into the mature cells that are being replaced (figure 1-1). ASC are different in 
part because, in the tissues, they have their own specialized environment called niche2, 17. For 
most stem cells the niche is poorly defined, but it is a complex microenvironment composed 
of extracellular matrix, differentiated cells, stem cells and their progeny, and factors secreted 
by the cells. The fate of the stem cells is controlled by this niche2. Very few ASC exist in each 
tissue, thereby making it a challenge to isolate them in the laboratory. Cells contain proteins 
called antigens, or surface markers, in their cell membranes. Each cell type has a different set 
of surface markers, protruding from the cell’s surface. By taking advantage of the uniqueness 
of these markers, different cells can be isolated and identified by modern techniques of cell 
biology.  
1.3 Why study stem cells? 
As a result of their ability to self-renew and their differentiation potential, stem cells are 
believed to have the potential to cure or treat a number of chronic diseases and injuries, such 
as diabetes, multiple sclerosis, heart diseases, Parkinson’s disease, osteoporosis, and spinal 
injuries18.  
 
Stem cells could potentially provide cells and tissues for transplantation therapy. Some 
diseases and injuries are caused by the death or dysfunction of one or a few cell types, for 
example diabetes, Parkinson’s disease, and spinal injuries. If such cells can be replaced by 
new functional cells made from stem cells, it could offer a lifelong treatment for these 
diseases or injuries. Furthermore, stem cells could potentially offer human tissues and cells 
that can be used for testing new human drugs. Often animal models are being used for these 
experiments, but drugs do not always have the same effect on humans as on animals because 
of species-specific differences. By having pure populations of human cells that are affected by 
a disease, new drugs could be tested in cultures of these cells. The same populations of cells 
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may also be used for toxicity testing. Populations of stem cells are also predicted to have a 
future application for preventing the development of a disease. For example, a supply of 
neuronal cells could be studied in detail to understand the mechanism of cell death in 
Parkinson’s disease.  
 
Following introduction of genes into stem cells by genetic engineering, the cells could be 
introduced into the body in order to produces proteins that act as therapeutic agents. This 
approach is called gene therapy.  
 
Due to lack of organ donors and limitations because of immunological rejections and physical 
size, stem cells may provide ways for obtaining tissues and organs for transplantation (tissue 
engineering). The patient’s own cells could be seeded on a bio-degradable scaffold that could 
allow the formation of a particular tissue.  
 
Studying cell differentiation will be important for the understanding of fundamental events in 
embryonic development that one day may explain the causes of birth defects and how to 
prevent them. It will also give valuable information that may help in understanding the 
development and function of cells and organs.  
 
In the future, stem cell research could conceivably give new technology and treatment options 
that scientists currently are unaware of.  
1.4 Adult stem cells versus embryonic stem cells 
Source and differentiation- and proliferation potential are probably the most important 
differences between ESC and ASC. Because ESC are derived from fertilized eggs that are 
destroyed during the procedure, there are ethical considerations concerning the use of these 
cells. Use of ASC is not associated with these same ethical issues because they are derived 
from borne individuals, so their derivation does not involve the destruction of a blastocyst, 
and also an informed consent can be given. It has therefore been argued that use of ESC 
should be avoided and the focus should be on ASC only. Today, most scientists agree that 
investigation of both types of cells is necessary to understand how these cells can be used in 
therapy. The advantages of ESC are that they can be expanded for many generations in an 
undifferentiated state and they can differentiate into all cell types in the body. Thus, in theory, 
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all cell types can be produced in quantities required for clinical applications. However, in 
spite of their promising potential, the use of ESC are not ready to be applied in therapy. The 
mechanisms behind differentiation are poorly understood, and the cells often differentiate 
spontaneously. When transplanted into a host, ESC frequently develop into teratomas 
(tumors). Pre-differentiation of ESC has been shown to decrease the likelihood of teratoma 
formation, and could represent a possible solution to this clinical obstacle. Human ESC-
derived oligodendrocyte progenitors did not show any signs of teratoma development after 
being transplanted into rats19. It is not known why pre-differentiated ESC do not develop into 
teratomas, but they could possibly have developed to a stage where they are restricted to 
differentiate into only one specific lineage. As they have differentiated beyond the point 
where differentiation to many different lineages is possible, they are not able to produce 
teratomas. Another limitation for the use of ESC is rejection of the cells after transplantation. 
ESC contain the donor’s HLA molecules in the cell membrane, and if the donor and recipient 
do not have the same set of HLA molecules when cells/tissues are transplanted from one 
person to another, the transplanted cells will be rejected by the recipient’s immune system20. 
Therefore, the recipient must use immunosuppressive drugs, which frequently cause severe 
side effects, to prevent rejection of the cells.  
 
Even though ASC have a more restricted differentiation and dividing potential compared to 
the ESC, they nevertheless have potential for treating diseases. Bone marrow transplantation, 
or hematopoietic stem cell transplantation, has been used in the clinic for decades, and several 
other clinical trials with ASC have shown promising results21, 22. Cancer development 
(teratomas) has not been observed for ASC used in humans. It has been suggested that stem 
cells that are injected into the body tend to migrate towards the site of injury, and that the 
surroundings of the injury can induce differentiation into the cell types required to repair the 
damaged cells/tissues23. Ideally, the patients own cells will be used in order to avoid rejection 
by the recipient, thereby avoiding the need for immunosuppressive drugs.  
1.5 Multipotent mesenchymal stromal cells 
1.5.1 Sources of multipotent mesenchymal stromal cells  
Multipotent mesenchymal stromal cells (MSC), previously referred to as mesenchymal stem 
cells, are multipotent, non-hematopoietic stem cells that are usually isolated from bone 
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marrow24-27 or adipose tissue28, 29, but can also be isolated from several other tissues such as 
skeletal muscle30, trabecular bone31, dermis32, blood33, periosteum34, teeth35, synovial 
membrane36, amniotic fluid37, placenta38 and umbilical cord blood39.  
 
1.5.2 Properties of human MSC 
MSC were first described by Friedenstein et al. more than three decades ago as colony 
forming unit-fibroblasts (CFU-F) because of their ability to adhere to plastic surfaces and 
form fibroblast-like colonies when plated at low densities25. This process involves flattening 
and spreading of the cells into their characteristic spindle-shape, which is very similar to that 
of fibroblasts (figure 1-4). In the microscope, MSC cultures appear to be a rather homogenous 
population of fibroblast-like cells. In fact, they consist of a heterogeneous group of progenitor 
cells with varying proliferation and differentiation potentials40, 41.  
 
 
Figure 1-4. Human MSC in culture.  
In vitro MSC have a shape resembling fibroblasts. 
Image magnified 200 X. 
  
 
Laboratories around the world use relatively different isolation and expansion methods, and 
also different approaches to characterize MSC. This makes it difficult to compare results 
between laboratories since it is not known if the cell populations are similar enough for direct 
comparison. Therefore, the Mesenchymal and Tissue Stem Cell Committee of the 
International Society for Cellular Therapy (ISCT) has proposed three criteria to define human 
MSC 42. First, the cells must adhere to plastic surfaces when cultured in tissue culture flasks. 
This is a well described property of MSC and is utilized for isolating the cells. Second, MSC 
should have a specific surface marker profile, and 95%, or more, of the MSC population 
should express CD105 (also known as endoglin), CD73 (also known as ecto 5’ nucleotidase), 
and CD90 (also known as Thy-1). MSC populations can often be contaminated with other 
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cells, especially hematopoietic cells. To ensure that the MSC populations are pure it is 
recommended that cultured MSC lack expression (≤ 2 % positive) of the hematopoietic stem 
cell marker CD34, the hematopoietic cell marker CD45, one of the two macrophage markers 
CD14 and CD11b and one of the two B-cell markers CD79α and CD19. HLA DR, which is 
expressed on professional antigen-presenting cells such as dendritic cells, B-cells and 
macrophages, should also be negative, but this molecule can be expressed by MSC if they are 
stimulated with interferon-γ43. If this is the case another term, for example “stimulated MSC”, 
should be used to distinguish them from the unstimulated MSC. Third, the cells must be able 
to differentiate to osteocytes, chondrocytes and adipocytes in vitro. These criteria are minimal 
requirements and apply only to human MSC. MSC from other species also display plastic-
adherence and trilineage differentiation, but the surface marker expression can vary between 
species44. As the field of MSC makes progress, these criteria will most likely require 
modifications, but with the current state of knowledge this is the best way of defining human 
MSC. By employing these criteria in studies the comparison between laboratories will most 
likely be facilitated and advance the progression in the MSC field. 
 
1.5.3 Human bone marrow multipotent mesenchymal stromal cells 
Human marrow multipotent mesenchymal stromal cells (hBM-MSC) are found at a very low 
frequency in the bone marrow. It has been estimated that hBM-MSC constitute between 
0.001% and 0.01% of the total population of nucleated cells in the bone marrow 24, 26. Due to 
this low frequency of hBM-MSC in the bone marrow, in vitro expansion of the cells is 
necessary prior to clinical studies. Both in vitro and in vivo, studies have shown that hBM-
MSC can differentiate into cells of mesodermal origin including osteocytes, chondrocytes and 
adipocytes26, 45, as well as tenocytes46, cardiomyocytes47, 48 and skeletal muscle49 (figure 1-5). 
There is evidence that hBM-MSC also possess the ability of differentiating into cells of non-
mesodermal lineages such as neural precursors49, 50 and hepatocyte-like cells51.   
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Figure 1-5. MSC can give rise to several mesodermal cell types indicated in the figure. See text for details.  
(Reprinted from Trends in biotechnology, volume 20, No 8, Makarand D. Risbud and Michael Sittinger, Tissue 
engineering: advances in in vitro cartilage generation, page 351-356, August 2002, with permission from 
Elsevier) 
 
Because of their ease of isolation and extensive differentiation potential, as well as their high 
in vitro expansion potential, hBM-MSC have been well characterized, and they are believed 
to have a great potential for cell therapy and tissue engineering. The hBM-MSC have 
demonstrated efficacy in clinical trials in children with osteogenesis imperfecta21, 22 and it has 
furthermore been shown that hBM-MSC might enhance engraftment and treat graft-versus-
host disease (GvHD) in allogeneic stem cell transplantation52-55. However, most information 
about hBM-MSC biology (MSC in general) has been derived from in vitro studies. Thus, little 
is known about the biology of these cells in vivo. 
 
1.5.4 hBM-MSC cell surface molecules 
As described above, ISCT has proposed minimum criteria for surface marker expression in 
human MSC. However, most laboratories test for other surface markers as well, both positive 
and negative, to get additional evidence. Because hBM-MSC populations are heterogeneous 
within the cultures, variable expression of markers can be observed. Today, autologous serum 
(AS) and foetal bovine serum (FBS) is commonly used when expanding hBM-MSC in vitro. 
There is a small difference in cell surface molecule expression when comparing hBM-MSC 
cultured in medium containing AS compared to that of FBS24 (table 1-1). None of the surface 
markers included in table 1-1, or in the minimum criteria from the ISCT, are cell-specific for 
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hBM-MSC, they are all expressed on other cells as well. Taken together, this illustrates the 
challenge of identifying these cells solely by surface markers, and furthermore underscores 
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Table 1-1. Cell surface molecule expression in hBM-MSC cultured in FBS and AS (Reprinted with permission 




1.5.5 hBM-MSC self-renewal and maintenance 
Self-renewal refers to the mechanisms that preserve the undifferentiated state of the cells, and 
is necessary to maintain the stem cell pool. In this way, self renewal ensures that the tissues 
always have a reservoir of stem cells in case of cell death, disease, or injury. A complex 
interplay between intracellular signals and extracellular signals in vivo, provided by the stem 
cell niche, regulates self-renewal and differentiation. Understanding the genes and signal 
transduction pathways that regulate stem cell function is crucial in order to apply these cells  
for clinical purposes.  
 
Recently, researchers have tried to identify a common pool of genes that underlie the stem 
cell phenotype by comparing global gene expression in different stem cells. Most of the gene 
expression profiling has been performed using ESC, hematopoietic stem cells (HSC), neural 
stem cells (NSC), and skin epithelial stem cells (SESC)56-61. These studies have provided 
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valuable knowledge about the molecular mechanisms that regulate self-renewal and 
maintenance, but there are inconsistencies between the results, and many questions remain 
unanswered. Self-renewal and maintenance of hBM-MSC has been less well studied 
compared to other stem cells. However, promising results have given some insights in the 
understanding of how hBM-MSC self-renew. Different cytokines and proteins including 
Wnts62-65, the Wnt signaling inhibitor Dickkopf-166, and tumor necrosis factor-α (TNFα)67 
have all been demonstrated to be involved in hBM-MSC self-renewal. The Wnt, Notch, bone 
morphogenetic protein (BMP) and the Hedgehog signaling pathways68, 69 are known to play 
roles in self-renewal and differentiation in other stem cells, and most likely these pathways 
also have an important role in the regulation of hBM-MSC self-renewal. Oct-4, Sox2 and 
Rex1, the transcription factors associated with pluripotency and self-renewal of ESC, are also 
expressed in hBM-MSC70. Another transcription factor, Nf-κB, has been shown to inhibit 
hBM-MSC differentiation and may also be important for self-renewal71. Understanding the 
exact involvement of the cytokines and their respective signaling pathways, as well as the 
function of the transcription factors, is difficult and far from accomplished due to their 
redundancy and the crosstalk between signaling pathways.  
 
1.5.6 hBM-MSC differentiation 
Differentiation is the process whereby an unspecialized cell (stem cell) develops into a 
specialized cell such as a chondrocyte, adipocyte, or osteocyte. Different signals in the 
surroundings of the unspecialized cell induce expression of a specific set of genes that 
determine what kind of cell that it will develop into. For a long time it was believed that 
hBM-MSC, and other ASC, were restricted to form only the cell types of the tissue/organ 
from which they originated and that differentiation proceeded in one direction only with the 
cells becoming gradually more restricted with each step. If this is true, stem cells are 
committed to differentiate when they receive the appropriate signal and can not go backward 
in development. However, evidence has suggested that cells may not be as irreversibly 
committed to differentiation along a specific developmental lineage as first believed49, 50, 72-74. 
There are some possible explanations as to how hBM-MSC (or other ASC) can generate 
differentiated cells beyond their tissue boundaries. Figure 1-6 explains how this may happen.  
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Figure 1-6. The figure shows an imaginary situation where cell A is a progenitor cell for one lineage (for 
example mesenchymal lineage) and cell B is a progenitor cell for another lineage (for example hematopoietic 
lineage). Early in development cell A and B had a common ancestor before they separated and developed 
further. The two-coloured (light pink and blue) cell represents this common ancestor. In the traditional view cell 
A can differentiate to cells of their own lineage (pink cell). If cell A is capable to differentiate to another lineage 
there are two possibilities of how this can be done. First, epigenetic modifications can switch the fate of cell A so 
it can directly develop to cell B. This situation is referred to as transdifferentiation. The other possibility is that 
cell A can go back to an earlier stage in development, to the stage where it adopts the properties of the common 
ancestor and then it can develop to cell B by reprogramming of the genome. When a cell reverts to an earlier 
developmental stage it is called dedifferentiation.(Reprinted with permission from Jan Brinchmann) 
 
 
If hBM-MSC are to be used in cell therapy it is important to identify and understand the genes 
that determine hBM-MSC differentiation (and dedifferentiation, transdifferentiation and 
reprogramming if it happens). Self-renewal and maintenance are closely related to 
differentiation, thus, it is a very intricate area. The major molecules and signaling pathways 
that are known to govern the well known trilineage differentiation of hBM-MSC will be 
briefly described below. 
Osteogenesis 
Osteogenesis is the formation and development of bone. Runx2 (also known as Cbfa1) and 
osterix are essential for osteogenesis75, 76. They are transcription factors for osteoblast related 
genes such as collagen type I, osteocalcin and bone sialoprotein. BMPs, especially BMP-6, 
induce osteoblast differentiation by up-regulation of Runx2 and osterix, which leads to 
increased production of osteogenic extracellular matrix77. The inflammatory cytokine TNF-α 
work the opposite way by suppressing transcription of Runx2 and destabilizing Runx2 
mRNA67. Wnt3a, a member (ligand) of the Wnt signaling pathway, suppress osteogenic 
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differentiation of hBM-MSC when it binds to a G-protein-linked receptor in the so-called 
canonical Wnt pathway64, while it induces osteogenic differentiation in the less known non-
canonical Wnt pathway78. In addition, Wnt signaling interacts with other signaling pathways, 
such as BMP signaling, to modulate the action of osteogenesis68. 
Chondrogenesis 
Chondrogenesis is the formation of cartilage, and depends on several parameters such as cell 
density, cell adhesion, and the activity of different growth factors. A number of genes have 
been associated with chondrogenesis, including the transcription factors sox9, sox5, sox6 and 
scleraxis, the extracellular matrix genes collagen type I, II and IX, aggrecan, decorin, 
biglycan, cartilage link protein, and cartilage oligomeric matrix protein. These genes are 
routinely used as positive markers for chondrogenesis, but the molecular mechanism 
regulating chondrogenesis is generally unknown. Several signaling molecules including 
members of the Wnt, transforming growth factor β (TGF-β), BMP, and growth and 
differentiation factor (GDF) families have been shown to stimulate chondrogenesis79-82. It has 
been suggested that downstream mediators of TGF-β and BMP signaling work together to 
activate genes responsible for chondrogenesis83. Various Wnts have different roles in 
chondrogenesis, for example Wnt1 inhibits chondrogenesis84, while upregulation of Wnt7a 
enhances chondrogenesis85. On the other hand, sustained Wnt7a expression inhibit 
chondrogenesis85.  
Adipogenesis 
Adipogenesis, or the development of fat, depends largely on the receptor peroxisome 
proliferator-activated receptor-γ (PPAR-γ)86-88 and the C/EBP family of transcription 
factors89. Also Wnt signaling plays a role during the adipogenic process. It prevent 
differentiation of preadipocytes to adipocytes through inhibition of PPAR-γand C/EBP-α90. 
Other interesting examples of adipogenic regulation are the ability of cell shape/cytoskeletal 
tension and tension-responsive proteins to regulate adipogenesis. It has been demonstrated 
that cell density, which affects cell shape and cytoskeletal tension, is a key regulator of hBM-
MSC commitment to the adipocyte lineages91.  
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1.6 Other areas of hBM-MSC biology 
Recently, other areas of hBM-MSC biology, such as trophic effects, immunoregulatory 
functions and homing have received a lot of attention. Most of these research areas are in their 
very infancy, and will only be described briefly. 
hBM-MSC as trophic mediators 
Although hBM-MSC can provide cells for cell therapy, they also secrete various cytokines 
and growth factors that can influence cells in their vicinity 92. These factors can have several 
effects such as immunoregulatory effects (see below), inhibition of apoptosis and scar 
formation, stimulation of angiogenesis (formation of blood vessels) and mitosis, and 
differentiation of other stem cells93, 94. Thus, hBM-MSC can influence tissue regeneration 
without differentiating into tissue-specific cells themselves10. This influence is called trophic 
or paracrine effect95 and may have potential applications in cell therapy. 
Immunoregulatory function of hBM-MSC 
Immunoregulatory effects of hBM-MSC can be considered trophic because cytokines and 
growth factors play a key role in this context55. However, it is mentioned separately from 
trophic effects because it has attracted tremendous interest recently. Normally, when 
mismatched cells (allogeneic cells) are transplanted to a host, the transplanted cells will be 
deleted by the host immune system96, 97. There is evidence that hBM-MSC avoid immune 
recognition and can inhibit different immune responses when transplanted52, 53, 98, 99. 
Furthermore in vitro studies also support the immunosuppressive role of hBM-MSC10, 55, 100, 
101
. Thus, hBM-MSC have potential applications in allograft transplantation. 
Homing 
Homing is the migration of hBM-MSC to various organs in the body. In case of injury or 
disease, signaling to the hBM-MSC niche is required for homing of hBM-MSC to the site of 
injury and differentiation to the cell type required for replacement. Several in vivo studies, 
where hBM-MSC have been administered intravenously, show that hBM-MSC engraft into 
the injured/diseased tissue21, 23, 102, 103. The molecular mechanism regulating hBM-MSC 
homing is poorly understood, but is thought to be a multistep process involving many 
different surface antigens, cell adhesion molecules, chemokines, cytoskeletal proteins, 
cytokines, growth factors, and proteolytic enzymes104-106.  
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1.7 Project background 
1.7.1 Gas tension in the bone marrow 
The hBM-MSC niche encompasses all the elements in the surroundings of the hBM-MSC 
when they are in their native state. There is almost no information about the hBM-MSC niche, 
but it is expected that hBM-MSC can intermingle not only with each other, but with other 
cells, including HSC, adipocytes, osteoblasts, endothelial, and stromal cells, as well as 
extracellular matrix and soluble factors secreted by the cells107. An important factor 
contributing to the hBM-MSC niche is gas tensions. The bone marrow is well circulated due 
to many small blood vessels (called sinuses) that perforate much of the bone marrow cavity 
enabling efficient gas exchange between cells and the environment. All the components in the 
hBM-MSC niche can alter the signaling pathways controlling self-renewal and differentiation. 
Thus, when investigating hBM-MSC it is important to consider the influence from the in vivo 
environment of the cells, such as the effect of different gas tensions.  
 
Traditionally, the term normoxia refers to the O2 tension in the incubators, which is 
approximately 19.7 kPa, or 20 %. Hypoxia refers to  O2 levels which are lower than normoxia 
108-110
. In this thesis, however, the term normoxia is used for the O2 tension surrounding the 
cells in vivo, since these conditions constitute the normal state for these cells. When the cells 
are removed from the body, they are introduced to unusually high O2 levels, and these 
conditions will in this thesis be termed hyperoxia. Hypoxia would then be O2 levels that are 
lower than normoxic conditions in vivo. 
 
hBM-MSC are adapted to the gas tensions found in the bone marrow microenvironment in 
vivo. At present, it is not possible to accurately measure gas tensions and their spatial 
variations in the bone marrow. However, the mean normal oxygen tension have been 
estimated to be between 5% and 9 %111-113 (normoxia), which is quite similar to that of many 
other tissues. Standard incubator gas tensions corresponding to 20% O2 and 5% carbon 
dioxide (CO2) are routinely used for in vitro expansion of hBM-MSC, and it is being 
overlooked that such conditions provide O2 levels that exceed the physiological O2 tension 
found in the bone marrow microenvironment. Thus, the cells are exposed to much higher O2 
tensions than under physiological conditions. The effect of this hyperoxia is unknown, but 
oxygen free-radicals or reactive oxygen species (ROS) could potentially damage key 
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molecular constituents of the cells114, 115. The formation of ROS is a normal consequence of 
essential biochemical reactions, and most cells and organisms have evolved mechanisms 
against its toxic effect in their normoxic state. However, when cells are removed from their in 
vivo environment and introduced to hyperoxia in vitro, it is possible that these mechanisms 
are inadequate to protect the cells.  
 
CO2 is another gas that also may influence the behaviour of hBM-MSC. The CO2 tension in 
the bone marrow is unknown, but it is not unreasonable to assume that it is in the range 
between 5% and 8 %, the same as in many other tissues (Mirtaheri, P. unpublished data). 
Thus, it is possible that cells would behave more naturally at in vitro oxygen tensions lower 
than 20% and CO2 tensions higher than 5%. 
 
1.7.2 Motivation for the project 
Verfaille et al. showed that certain clones of rat MSC-like cells, called multipotent adult 
progenitor cells (MAPC), showed pluripotency when expanded in an atmosphere of 5% O2, 
and a serum concentration of 2%116. The cells were plated at low densities, approximately 300 
cells/cm2. Under these culture conditions, the cells had high expression of OCT-4 which is 
used as a marker for pluripotent ESC. However, when transferred to hyperoxia (20% O2) the 
cells lost OCT-4 expression and could never retain it. Thus, the low O2 tension was a requisite 
for pluripotency of these clones. Because of its association with pluripotency, it is desirable to 
have increased OCT-4 mRNA levels in multipotent stem cells as well. This is an indication 
that the cells are in a more immature, and undifferentiated state. 
 
1.7.3 Isolation of hBM-MSC 
Traditionally, hBM-MSC are isolated from the bone marrow-mononuclear cell (BM-MNC) 
fraction based on their adherence to plastic surfaces. A disadvantage with this method is the 
undesirable contamination of hematopoietic cells, such as adherent CD14+ monocytes. 
Enrichment of hBM-MSC can be achieved partly by depleting monocytes from the BM-MNC 
fraction before culturing the cells, and by expanding and passaging the cells. Previous 
observations from Dr. Brinchmann’s laboratory indicate that there is a difference in monocyte 
contamination when expanding the cells in FBS and AS: more monocytes adhere to the 
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culture substrate when expanding the cells in FBS. Therefore, it is possible that depletion of 
CD14+ cells is unnecessary when using AS as serum supplement. This would facilitate the 
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1.8 Aims of the study 
Based on the results from Verfaillie et al, this study aimed at examining the in vitro effects of 
different incubator gas tensions on polyclonal hBM-MSC populations. To do this, hBM-MSC 
were cultured in six different gas tensions (table 2-1, page 36), and the following aims were 
pursued: 
1) To assay the proliferative capability of hBM-MSC cultured in the different gas 
tensions. 
2) To compare expression of specific genes, which are known to regulate self-renewal 
and differentiation in ESC. 
3) To compare differences in global gene expression. 
 
Due to the observed decrease in monocyte contamination when expanding hBM-MSC in AS, 
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2. Materials and methods 
2.1 Theoretical background 
2.1.1 Bone marrow mononuclear cells 
The first step in isolation of hBM-MSC from bone marrow is to isolate BM-MNC. This 
procedure is based on a gradient centrifugation method developed by Arne Bøyum in 1968117 
(figure 2-2).  
 
 
Figure 2-2. After centrifugation at 800 g for 20 minutes four distinct layers are formed. The BM-MNC fraction 
is the greyish layer between the plasma/medium and the Lymphoprep. See text for details. 
 
The bone marrow aspirate is first diluted in medium (or physiological saline) and then added 
carefully on top of a centrifugation medium called Lymphoprep, which has a density of 1.077 
g/cm3, followed by centrifugation. Cells in the bone marrow have different densities, and the 
cells with a higher density than 1.077 g/cm3 will go through the Lymphoprep and to the 
bottom of the centrifugation tube (erythrocytes and granulocytes), while the cells with a lower 
density (BM-MNC) will stay on the top of the Lymphoprep. 
 
2.1.2 MACS® Cell Separation technology 
MACS technology is one of the standard methods for cell separation. It is based on three 
components: MACS microbeads, MACS columns and MACS separators. MACS microbeads 
are small dextran particles (~50 nm in diameter) with an iron core  that are coupled to highly 
specific antibodies that bind to specific structures on the surface of specific cell types (directly 
or indirectly). The separation process takes place within a MACS column that is placed in a 
MACS separator, a strong magnet. The column consists of an iron matrix which, when the 
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magnet separator is applied, provides a magnetic field that retains labeled cells inside the 
column, while unlabeled cells pass through (figure 2-3).  
 
 
Figure 2-3. To the left: cells are added to a column that is placed inside a magnet. Cells with MACS microbeads 
coupled to them (blue cells) are retained inside the column because of the magnetic field, while unlabeled cells 
are passed through and can be collected (negative selection). To the right: the column is taken out of the magnet, 
medium is added, and a piston is used to elute the labeled cells (positive selection) (Reprinted with permission 
from Tor Lea).  
 
If the unlabeled cells are collected for use, a negative selection has been performed. 
Alternatively, if the desired cells are those retained inside the column (labeled cells), they can 
be eluted and collected for use. This is called a positive selection.  
 
There is no need to remove MACS microbeads from cells after separation because they are 
biodegradable. They are not known to interfere with structure, activity or function of the 
labeled cells, and they are too small to interfere with the fluorescence signal used in flow 
cytometry. Hence, they are compatible with flow cytometry analysis, microscopic analysis, 
molecular biology experiments, cell culture and in vivo experiments.  
 
2.1.3 Nanodrop® ND-1000 Spectrophotometer 
Nanodrop® ND-1000 is a spectrophotometer that measures sample sizes as low as 1µl. The 
sample is placed between two pedestals that employ surface tension to hold the samples in 
place, and a pulse of xenon light is passed through the sample. The light passing through the 
sample is analyzed by a spectrophotometer and special software stores the results on a 
computer. It is sufficient to wipe the pedestal with a dry tissue paper before measuring 
another sample. Hence, several measurements can be done in seconds with high accuracy and 
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reproducibility. Nanodrop® ND-1000 can measure absorbance of DNA, RNA, dyes, proteins, 
and microbial cell culture OD. In this thesis, Nanodrop® ND-1000 was used for measuring 
RNA concentration and quantifying RNA purity. RNA concentration is calculated 
automatically by the computer. The ratio of OD260/OD280 is used to assess the purity of the 
RNA. Pure RNA has a ratio of ~ 2.0 (details are described in Nanodrop’s ND-1000 
spectophotometer V3.3 user’s manual).  
 
2.1.4 Agilent® 2100 Bioanalyzer 
Agilent 2100 bioanalyzer is a microfluidics platform offering solutions for analysis of DNA, 
RNA, proteins, and cells. In this thesis the bioanalyzer was used to determine RNA integrity 
before microarray analysis. The method is based on electrophoretic assays in a chip format 
containing microchannels and sample wells. During the procedure, the microchannels are 
filled with a gel containing a fluorescent dye. Once the wells and channels are filled the chip 
becomes an electrical circuit and the samples are added. Charged molecules are then 
electrophoretically driven by a voltage gradient. The fluorescent dye will intercalate into the 
molecules and the complexes will be detected by a laser-induced fluorescent. Data is then 
translated into gel-like images and electropherograms, and a standard curve is used to 
determine the migration time and fragment size. Results like sample concentration, and the 
RNA integrity number (RIN) are stored on a computer. RIN indicates RNA integrity. The 
RIN software algorithm is based on a numbering system from 1 to 10, with 1 being the most 
degraded profile and 10 being the most intact (details are described in Agilent 2100 
bioanalyzer expert user’s guide). 
 
2.1.5 Real-time RT PCR 
In this study real-time RT PCR was a central analysis method, and the method is therefore 
described in detail. Real-time RT PCR is a powerful tool for quantification of nucleic acids 
because of its high specificity, sensitivity and reproducibility118. The process of real-time RT 
PCR involves four steps: (1) preparation of RNA, (2) reverse transcription (RT) of RNA to 
complementary DNA (cDNA), (3) amplification of target cDNA by real-time RT PCR, and 
(4) data analysis119. Due to the exponential amplification of target template during PCR, the 
products generated are directly proportional to the amount of template prior to the start of the 
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PCR process119. In real-time RT PCR it is the initial amount of template that is quantified, 
rather than the amount of target accumulated at the end of the PCR process as in traditional 
PCR119. During the first PCR cycles the products generated increase exponentially. 
Thereafter, mainly due to reagent limitations, presence of PCR inhibitors in the samples, and 
accumulation of inorganic pyrophosphate (released as a result of nucleotide incorporation), 
the polymerase reaction eventually slows down and the PCR product is no longer being 
doubled at each cycle (figure 2-4). Therefore, variable amount of PCR product accumulate at 
the end of the reaction, making traditional PCR unreliable; it gives no information about the 
initial amounts of target templates that were present in the samples. Hence, traditional PCR 
can only be used for non-sensitive semi-quantification, or to distinguish a positive sample 
from a negative sample. Only during the exponential phase, when products are being doubled 
at each cycle, is it possible to extrapolate back in order to determine the initial amount of 
template. Real-time RT PCR measures PCR products as they accumulate (in real time) and 
allows for quantification in the exponential phase and therefore removes the variability 
associated with traditional PCR118. This gives real-time RT PCR a major advantage over 
traditional PCR. The real-time RT PCR system is based on the detection and quantification of 
a fluorescent probe that binds to the product formed118. The fluorescence intensity signal 
reflects the amount of PCR product formed, and thereby makes it possible to monitor the 
accumulation of products as the PCR reaction proceeds. The fluorescence signal is considered 
a real signal only when it is detected above an arbitrary threshold chosen by the computer. 
The fractional PCR cycle number at which the fluorescent signal passes the threshold value is 
defined as CT and will always occur during the exponential phase during the early cycles of 
PCR (figure 2-4). The higher the initial copy number of the target template, the sooner a 
significant increase in fluorescence (lower CT value) is observed.  
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Figure 2-4. PCR amplification plot.  
A typical amplification follows the red line, with little change in fluorescence (PCR product) in the initial cycles 
followed by an exponential growth phase and a plateau phase where amplification decreases. Traditional PCR 
measures the amount of product generated at the end of the reaction (plateau), while real-time RT PCR measures 
the amount of product in the exponential phase. Baseline is defined as the initial cycles of PCR in which there is 
little change in fluorescence signal. Threshold is set to be above baseline and sufficiently low to be within the 
exponential phase. CT is the cycle number at which the fluorescence passes the threshold.     
 
 
Generally two quantification strategies can be performed: absolute quantification and relative 
quantification (RQ). Absolute quantification determines the exact input copy number of the 
target template by comparison with standard curves118. RQ is also known as the comparative 
CT method (2-∆∆Ct). This method determines the change in expression of a target template 
relative to some reference group (calibrator), such as an untreated control or a sample at time 
zero in a time-course study120. RQ eliminates the need for standard curves and uses 
mathematical equations to provide accurate comparison between the initial levels of template 
in samples, without requiring the exact copy number of the template. For most gene 
expression studies RQ is the most relevant approach. For example, stating that a given 
treatment increased the expression of a gene by 10 fold may be more relevant than stating that 
the treatment increased the expression of the gene from 1000 copies to 10000 copies. Thus, 
RQ was the preferred choice in this thesis. 
 
Certain assumptions and testing of these assumptions are required for RQ data to be valid: (1) 
a critical step in real-time RT PCR is to find proper amounts of RNA that will be efficiently 
reverse transcribed to cDNA. The amount of cDNA produced must reflect the amount of 
RNA input for the results to be sensitive and accurate121. This can be tested by making a 
dilution series of the RNA. After RT, the cDNA is subjected to real-time RT PCR, with all 
samples amplifying the same target template (preferably a housekeeping gene, see below). If 
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the amount of RNA input is proportional to the amount of cDNA produced, then the plot of 
log RNA input versus CT value will give a linear curve. Then it is safe to use these amounts of 
RNA in the RT reaction. If too much RNA is loaded into the RT reaction, not all RNA will be 
copied to cDNA due to lack of reagents and presence of RT inhibitors in the sample material. 
This will give a falsely high CT value which will not correspond with the linear curve. 
 
(2) In gene expression experiments, the real-time RT PCR is normalized for the amount of 
RNA added to the RT reaction by an internal RNA reference gene, which is a cellular RNA 
that is amplified simultaneously with the target. The accuracy of the normalized data is highly 
dependent on the reliability of the internal reference120. Therefore, their expression levels 
should be expressed at constant levels in different experimental conditions. The most common 
genes used for normalization are housekeeping genes like GAPDH, 18S rRNA , β2-
microglobulin and β-actin. However, none of these internal references are ideal. All have 
been shown to be modified by different experimental treatments122. Therefore, it is highly 
recommended that the internal reference gene is validated for each experiment to determine 
that gene expression is unaffected by the experimental treatment120. This can be performed by 
using a modified version of the 2-∆∆Ct method called 2-∆C’t 120. In this situation, normalisation 
must be carried out to some measurement external to the real-time RT PCR experiment. The 
most common method is to use UV absorbance to determine the amount of RNA added to 
each RT reaction. Real-time RT PCR is then set up using cDNA derived from the same 
amount of RNA input for all samples. 
 
(3) The amount of target template in a sample is given by 2-∆∆Ct (derivation of this equation is 
described in Applied Biosystems User Bulletin No. 2 (P/N4303859)), where ∆∆CT = ∆CT 
(sample) - ∆CT (calibrator), and ∆CT is the CT value of the target gene subtracted from the CT 
value of the internal reference gene that is amplified simultaneously as the target gene. This 
calculation is the basic principle of RQ, and is only valid if the amplification efficiency of the 
target template and the internal reference is approximately equal (above 90 %)118. This can 
easily be assessed by looking at how ∆CT varies with template dilution. A plot of the log 
RNA input versus ∆CT is made and if the slope of the regression line is close to zero (between 
0.1 and -0.1), the amplification efficiency of the two is similar enough, and RQ can be used. 
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2.1.6 Microarray technology 
Microarray enables gene expression measurements of thousand of genes in a single sample. 
Although relatively new, this method has been proven to be extremely useful within 
molecular biology. In this type of analysis, most of the genes of an organism are represented 
by oligonucleotide, cDNA, or DNA sequences (probes) that are spread out on a high-density 
array. The array contains several thousand of spots and each spot consist of hundreds of 
thousand identical probes that represent one gene (one gene may be represented by many 
spots). Usually, mRNA from cells, or tissues, is reverse transcribed to cDNA and labeled with 
a fluorescent dye. The labeled cDNA is then applied to the array and because of the 
hybridization property of nucleic acids, any sequence that finds a complementary strand will 
bind to a specific spot (figure 2-5) and a fluorescent signal is created123.  
 
Figure 2-5. Labeled cDNA hybridize to their complementary probe. For simplicity, only a few probes and spots 
are shown. See text for details.   
 
The signal is picked up using a scanner and a computer determines the amount of sample 
bound to each spot on the array. The amount of fluorescence is assumed to be proportional to 
the amount of each mRNA in the original biological sample. There are many possible sources 
of errors in microarray analysis, such as variation within and between oligonucleotide spots, 
efficiency of dye-incorporation, hybridization efficiency, and accuracy and fluctuations in 
scanning the fluorescent signals123. There are many statistics and data analysis tools available 
for processing these variations123. It is important to use these tools carefully and to process 
and analyze the data while keeping the sources of variations in mind. Several types of 
microarray technologies (platforms) for measuring gene expression are availible124. In this 
thesis the beadarray technology from Illumina was used. 
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2.1.7 Illumina’s BeadArray technology 
Conventional microarrays are manufactured by spotting or synthesizing probes onto a solid 
phase at known locations125. In contrast, the beadarray technology involves random assembly 




Figure 2-6. A pool of 3 µm silica beads is loaded by a 
self-assembly process into the microwells in the 
beadchip. Each bead is represented on the beadchip ~ 30 
times. (Reprinted with permission from Illumina).
 
Each bead is covered with hundreds of thousand copies of a specific oligonucleotide 
consisting of a 50 bp probe and a 29 bp address sequence. The probe acts as the capture 
sequence and the address sequence acts as a decoding sequence that enables the identification 
and location of the bead on the array (figure 2-7).  
 
 
Figure 2-7. Each bead is coated with hundreds of thousands copies of the same probe, to which labeled cRNA 
can hybridize. Concatenated to the probe is a short address sequence, which is used to identify the bead. 
(Reprinted with permission from Illumina).  
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The address sequence is designed such that it has no sequence homology to genomic 
sequences within the genome to be studied. The decoding process is based on several 
sequential hybridizations of a few dye-labeled oligonucleotides to the address sequence. An 
algorithm then identifies the probe and its location by tracking the oligonucleotides 
hybridizing to the address sequence126. Each bead type is represented on the surface of the 
array an average of more than 30 times. This redundancy results in high data quality, because 
each signal created during hybridization is based on the average of many independent 
readings. It also enables the removal of outliers without affecting the overall results. 
Randomly assembled bead assays results in very high density (~40,000 times higher than a 
typical spotted array) which gives small assays and, therefore, very small volumes of sample 
and reagents are needed. Briefly, the process of whole genome gene expression using the 
Illumina beadarray technology can be divided into four steps: (1) sample preparation, (2) 
sample hybridization, (3) scanning and (4) data analysis. Because of the many possibilities of 
errors during the microarray procedure, seven control categories are built into the beadarray 
system. These controls cover every aspect of an array experiment from the biological 
specimen, to sample labeling, to hybridization, signal detection, and negative controls that 
defines the system background (details are described in the “Whole-Genome Gene Expression 
for Beadstation” user manual from Illumina).  
 
2.1.8 Genespring GX 7.3.1 
The Genespring software provides statistical tools for fast visualization and analysis of 
microarray data. It is easy to use and designed specifically for the needs of biologists. 
Genespring enables visualization of expression data using a wide range of graphical displays 
such as 2D and 3D scatterplots, chromosome maps, box plots, and pathway diagrams. Using 
Genespring it is easy to identify target genes and their function, assess changes in gene 
expression, determine if a particular gene is a member of a known pathway, create annotated 
lists of genes identified through graphical tools, uncover statistically meaningful data, create 
experiments that link the expression data to a variety of parameters, and ensure data quality 
with powerful statistical tools and normalization methods. (For details: 
www.agilent.com/chem/informatics). 
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2.2 Adjustment of the incubators 
One week before the experiment started six different incubators were adjusted with the gas 
tensions shown in table 2-1, and with a temperature of 37oC, and 92 % humidity. 
 
Table 2-1. Different incubator gas tensions  
used for culturing hBM-MSC.  






         
2.3 Preparation of autologous serum 
Venous blood (450 ml) from the bone marrow donor was drained into blood bags. The blood 
was then transferred quickly to 10 ml vacutainers without anticoagulants, and allowed to clot 
for 3-4 hours at 4oC. After clotting, the blood was centrifuged at 1800 x g for 20 minutes at 
4oC, and serum was collected. Subsequently, the AS was passed through a 0.45 µm pore size 
filter, and then through a 0.20 µm pore size filter. Aliquots of the sterile AS were stored at -
20oC.  
2.4 Isolation and culture of hBM-MSC 
2.4.1 Isolation of BM-MNC 
Syringes were coated with monoheparin (to avoid coagulation) and used to obtain between 
50-90 ml bone marrow aspirate from the iliac crest of each of six donors after informed 
consent. The bone marrow aspirate was quickly diluted 1:3 in basal medium (D-MEM/F12 
(1:1) + Glutamax from Gibco) supplemented with 100 units/ml penicillin, 100 µg/ml 
streptomycin and 2.5 µg/ml amphotericin B. The diluted aspirate was then added carefully to 
50 ml tubes containing 15 ml Lymphoprep and centrifuged at 800 x g for 20 minutes, without 
breaks. After centrifugation, the layer containing the BM-MNC was collected in new tubes 
and washed twice with medium at 300 x g for 10 minutes. Pellets were resuspended, pooled in 
a new tube, and the cells were counted. The BM-MNC fraction from donor 1, 2, and 3 was 
 O2 CO2 
1.  20 %  5 % 
2. 20 %   7.5 % 
3. 6 % 5 % 
4. 6 % 7.5 % 
5. 9 % 5 % 
6. 9 % 7.5 % 
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depleted of CD14+ cells before being established in culture, while the BM-MNC fraction from 
donor 4, 5, and 6 were established directly in culture.  
 
2.4.2 Use of MACS® Cell Separation system  
The MACS system was used to test out the necessity of removing adherent CD14+ monocytes 
from the BM-MNC fraction. Cell separation was performed using protocols and reagents from 
the manufacturer. Briefly, the cells from donor 1, 2, and 3 were washed in “superMACS 
buffer” and labeled with MACS microbeads coupled to mouse anti-human CD14 monoclonal 
antibody. Subsequently, the cells were added to a column inside a magnet and a negative 
selection was performed. The CD14- cells passed through the column and were collected for 
further use, while the CD14+ cells were retained inside the column. The CD14- cells were 
counted and seeded out in culture flasks.  
 
2.4.3 Culture of hBM-MSC 
The cells were allowed to adhere overnight. At day 1, non-adherent cells were discarded, and 
adherent cells were washed three times with 30 ml medium and cultured in fresh culture 
medium. Culture medium was replaced every 3 or 4 days until 40-50 % confluence was 
reached. Subsequently, cells were detached using trypsin EDTA and replated at 3000 
cells/cm2. Cells were cultured for three passages and cell pellets for real-time RT PCR and 
microarray analysis were made at passage 2 and 3. The rest of the cells were frozen down as 
living cells. The culture medium consisted of D-MEM/F12 supplemented with 10% or 20% 
AS, 100 units/ml penicillin, 100 µg/ml streptomycin, and 2.5 µg/ml amphotericin B. 
Amphotericin B and 20% serum were used in the culture medium until the first passage. After 
the first passage amphotericin B was removed, and 10% instead of 20% AS was used for 
further cell cultures. Culture media were always pre-incubated in their respective incubator, 
without AS, for at least 2 hours before use. AS was always added at the same time as the 
cells. Pre-incubation of the culture medium was done in an attempt to reach equilibrium 
between O2 and CO2 in the gas and the liquid phases before adding the cells. Previous results 
have shown that it takes 2 hours to establish equilibrium between the gas and the liquid 
phases when the height of the medium is 4 mm (unpublished data from Dr. Brinchmann’s 
laboratory). This height corresponds to the amount of culture medium used in this study. It 
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was decided not to include AS in the culture medium during pre-incubation. The reason is that 
AS contains factors that are important for the attachment of the cells to the plastic surfaces, 
and pre-incubation with AS may influence the attachment of the cells in an unknown way. 
Experiments have indicated that less hBM-MSC attach to the culture surface when pre-
incubating medium with AS (unpublished data from Dr. Brinchmann’s laboratory). 
Trypsination –  detachment of the cells 
Detachment of the cells was performed according to protocols from the manufacturer. Briefly, 
the used culture medium was transferred to a sterile tube, and the monolayer of cells was 
washed with trypsin to remove all traces of serum. New trypsin was added, and the flask was 
incubated at 37oC until all cells had detached from the surface. The trypsin containing the 
cells was then transferred to the used culture medium in order to inactivate the trypsin. Cells 
were then centrifuged at 300 x g for 10 minutes. The pellet was resuspended in fresh culture 
medium, and cells were counted and seeded in new culture flasks. 
Counting cells 
Cells were counted using a KOVA chamber according to protocols from the manufacturer. 
Briefly, 18 µl cell suspension was mixed with 2 µl ethidium bromide/acridin orange and 
transferred to the KOVA chamber. Cells were visualized and counted using a fluorescence 
microscope. 
Freezing down living cells 
The freeze down medium, consisting of D-MEM/F12 supplemented with 20% AS and 5% 
DMSO, was mixed and filtered through a 0.25 µm pore size membrane. Cells were 
centrifuged at 300 x g for 10 minutes in culture medium. Pellets were resuspended in 1 ml 
freeze down medium, transferred to cryotubes (1.5 ml) and quickly transferred to -70oC for 
storage. This rapid freeze down technique has been shown to yield cells with at least the same 
viability as the more elaborate technique of gradually adding DMSO-containing medium 
(unpublished data from Dr. Brinchmann’s laboratory).  
Freezing down pellets 
Approximately 1 – 2 x106 cells from passage 2, and 3 were centrifuged in RNase free 
Eppendorph tubes at 320 x g for 2 minutes, supernatant was discarded and the pellets quickly 
transferred to liquid nitrogen. Pellets were then stored at - 70oC.  
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2.5 RNA isolation and DNase treatment 
RNA was isolated using the RNaqueous®-4 PCR Kit from Ambion (Ambion, Austin, TX). All 
materials and solutions were supplied with the kit. Briefly, 1 – 2 x106 cells from passage 2 
were homogenised in lysis solution. The cell lysate was applied onto a filter cartridge column 
and DNA, proteins, tRNA, and other debris were washed away using two different washing 
solutions. Subsequently, RNA was eluted from the column followed by DNase treatment to 
ensure removal of contaminating DNA. RNA concentration and RNA integrity was assessed 
before storing RNA at -70oC.  
2.6 RNA measurements and RNA integrity 
2.6.1 Determining RNA concentration and RNA purity 
RNA concentration was measured with the Nanodrop® ND-1000 Spectrophotometer 
following protocols supplied by the manufacturer. Briefly, before start-up the pedestal 
surfaces were cleaned to remove dirt and prevent sample carry-over that can cause erroneous 
absorbance readings. The program ND-1000 3.2.0 was opened and RNase free water was 
added on the pedestals to initialize the spectrophotometer. Before starting the measurements, 
the spectrophotometer was blanked. RNA concentration and RNA purity were determined by 
analyzing 2 µl RNA solution. The results were stored on the computer.  
2.6.2 RNA integrity 
In Dr. Brinchmann’s laboratory, RNA integrity is routinely checked by electrophoresis on a 
1% agarose gel. At the Microarray core facility at Rikshospitalet - Radiumhospitalet they use 
the Agilent® 2100 Bioanalyzer system to check RNA integrity. It is always recommended that 
RNA integrity is checked before starting analysis such as real-time RT PCR and microarray. 
Therefore, RNA integrity was checked by two different methods in this thesis: on 
elecrophoresis before real-time RT PCR analysis, and by the Agilent® 2100 Bioanalyzer 
system before microarray analysis.  
Agarose gel electrophoresis of RNA 
0.5 g agarose powder was added to 50 ml TAE and heated in the microwave oven. After 
cooling, a drop of ethidium bromide was added and the solution was poured into a mould. 
Approximately 700 ng RNA was mixed with 0.5 X formadide loading dye and set to 
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incubation at 70oC to denature the RNA. After denaturation the samples were added to the 
gel, and separation was performed at 80 V for 30-40 minutes. Finally, UV-light was used to 
visualize the separated bands and pictures were taken. 
Agilent® 2100 Bioanalyzer 
Evaluation of RNA integrity using the Agilent Bioanalyzer was performed at the Microarray 
core facility at Rikshospitalet-Radiumhospitalet, using the Agilent Bioanalyzer 2100 RNA 
6000 Nano assay following protocols from the manufacturer. Briefly, the gel-dye mix was 
prepared and loaded into the chip. Subsequently, sample buffer, ladder and the sample were 
loaded into the wells and the chip was run in the Bioanalyzer.   
2.7 cDNA synthesis for real-time RT PCR 
Reverse transcription was performed using the High Capacity cDNA Archive Kit from 
Applied Biosystems (Applied Biosystems, CA, USA) according to protocols from the 
manufacturer. Half amount of reagents was used, and all reagents were supplied with the kit. 
Briefly, 200 ng RNA was diluted with RNase free water and mixed with pre-made mastermix 
in a total volume of 50 µl. Reverse transcription was performed on the Geneamp® PCR 
system 9700. Thermal parameters were 25oC for 10 minutes followed by 37oC for 120 
minutes. cDNA was stored at -20oC before use. 
2.8 Real-time RT PCR 
Real-time RT PCR analyses were performed on the 7300 Real-Time RT PCR system from 
Applied Biosystems using reagents and following protocols from the Taqman® Gene 
Expression Assay Protocol (Applied Biosystems).  
 
2.8.1 Gene expression analysis 
Taqman assays for the following target genes were selected: OCT-4, SOX2, NANOG, KLF4, 
and C-MYC (see table 2-2 for assay ID details). Briefly, 6 µl cDNA was mixed with “Taqman 
Universal PCR Mastermix 2X (No AmpErase UNG)”, RNase free water, and “Taqman gene 
expression assay” according to ratios described in the protocol. The mix was transferred to a 
96-well plate, and RQ was performed using the 7300 System SDS software. The thermocycler 
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parameters were 95oC for 10 minutes followed by 40 cycles of 95oC for 15 seconds and 60oC 
for 1 minute. All samples were run in triplicates. Following the instructions in the protocol 
and using 6 µl cDNA in the set up, the RNA input for every replicate corresponds to 6 ng. To 
check for possible contamination, RNA and water were used as controls. All samples were 
scaled according to the expression level of standard incubator air (20% O2, 5% CO2 - 
calibrator).  
 
Table 2-2.  Assay ID for targets used in Real-time RT PCR. 
 
Target Assay ID 
OCT-4 (POU5F1) Hs00742896_s1  
SOX2 Hs00602736_s1  
NANOG Hs02387400_g1 
C-MYC Hs00153408_m1 
KLF4 Hs 00358836_m1 
GAPDH Hs 00266705_g1 
 
Before the gene expression analysis was performed, the efficiency of the RT reaction, 
validation of the internal reference gene, and the amplification efficiency of the targets and 
the internal reference were examined. 
 
2.8.2 Efficiency of RT 
To find an amount of RNA input that was proportional to the amount of cDNA produced in 
the RT reaction, a 2-fold dilution series of RNA was made. The least concentrated sample 
contained cDNA derived from 0.9 ng RNA, and the most concentrated sample contained 
cDNA derived from 15 ng RNA. cDNA from all samples were amplified using real-time RT 
PCR, and a plot of log RNA input versus CT value was produced. To ensure reproducible 
amplification through all cycles, a highly expressed gene is preferred to be the amplification 
target in this kind of experiment. Hence, GAPDH was chosen as target. 
 
2.8.3 Validation of internal control 
GAPDH was chosen as internal reference gene for all experiments. To validate that GAPDH 
was not affected by the different gas tensions the modified version of 2-∆∆Ct, 2-∆C’t, was 
applied120. This equation enables relative gene expression measurements when only one gene 
is being studied. Thus, the target gene and the internal reference gene are one and the same. 
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RNA input corresponding to 6 ng RNA was used as the external measurement for 
normalisation.  
 
2.8.4 Amplification efficiency 
To validate the amplification efficiency, test samples that are known to express the target 
genes at high levels are required to ensure amplification. Alternatively, a purified PCR 
product can be used. Embryonic carcinoma cells (ECC) express high levels of all the target 
genes used in this real-time RT PCR experiment. RNA isolated from ECC was therefore used 
as test samples for all target genes. A 3-fold dilution series of RNA was made, and real-time 
RT PCR was set up using cDNA derived from the diluted samples. A plot of template dilution 
versus ∆CT was made to assess amplification efficiency. The least concentrated sample 
contained cDNA derived from 0.025 ng RNA, and the most concentrated sample contained 
cDNA derived from 6 ng RNA. 
  
2.9 Microarray   
2.9.1 Illumina Human-6 v2 Expression Beadchip 
Illumina’s beadarray technology was used following protocols from the manufacturer. 
Briefly, RNA integrity was checked and biotin-labeled cRNA was produced by reverse 
transcription followed by in vitro transcription, using the Illumina® Totalprep RNA 
amplification Kit (Ambion, Inc, Austin, TX). Labeled and amplified cRNA was applied to the 
Human-6 v2 Expression Beadchip (containing 46718 probes – many duplicates) and allowed 
to hybridize at 55oC overnight on the BeadChip Hyb Wheel. The following day the Beadchip 
was washed, blocked, and a signal was developed with streptavidin-Cy3 using FluoroLinkTM 
CyTM3 (Amersham Biosciences, Piscataway, NJ). The Beadchip was then scanned with the 
Illumina Beadstation 500. The scanned image files were imported into the Illumina 
Beadstudio software for basic quality control of the data. The resulting data files were 
exported to Genespring GX 7.3.1 (Agilent Technologies, Santa Clara, CA) for further gene 
expression analysis.  
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cRNA amplification was performed at the Microarray core facility at Rikshospitalet-
Radiumhospitalet, while hybridization, washing, scanning and Beadchip quality analysis was 
performed at Service XS in Leiden, the Netherlands. 
 
hBM-MSC expanded in three different gas tensions were analyzed by the Illumina Beadchip 
system: 
1. 20% O2 and 5 % CO2 
2. 6 % O2 and 7.5 % CO2 
3. 9 % O2 and 5 % CO2 
 
2.9.2 Genespring GX 7.3.1 
Briefly, the raw data were normalized by (1) Data transformation: Set measurements less than 
10.0 to 10.0, (2) Per chip: Normalize to 50th percentile and (3) Per gene: Normalize to median. 
The three donors were used as biological replicates and “Gas tension” was used as parameter 
when creating the experimental design. In order to evaluate the quality of the samples, 
hierarchical clustering (condition three) was applied. Before starting analysis, scatterplots of 
the different gas tensions, with 2-fold as cut-off, was applied to obtain a rough and visual 
overview of the gene expression differences between the gas tensions. Afterwards, genes with 
large spread (more than one standard deviation from the mean) were removed. Furthermore, 
genes with less than 1.5-fold change difference across the experiment were excluded. 
Thereafter, a one-way ANOVA, with a false discovery rate of 0.05, was used to determine 
genes with statistically differential expression between the different gas conditions. The one-
way ANOVA analysis was performed both without and with multiple testing correction. The 
genes that passed the one-way ANOVA analysis were used to make pairwise comparisons 
between the different gas tensions. For this purpose volcano plots, with 2-fold difference and 
0.05 as P-value cut-off, was applied. 
2.10 Statistical analysis 
Figures for cell counts and real-time RT PCR data, were created using GraphPad Prism 5. All 
statistical analysis on the real-time RT PCR data, were performed using Origin 7.5 SR 6 
version. A Two Sample t-Test was used to test for significant differences in gene expression 
compared to the control groups (calibrator).  
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Figures for microarray data were obtained from the Genespring GX 7.3.1 program. The 
statistical analysis on the microarray data, were performed using the statistical package 
integrated in Genespring GX 7.3.1. A one-way ANOVA was used, both without and with the 
Benjamini and Hochberg multiple testing correction, in order to compare how the different 
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3. RESULTS 
3.1 Depletion of CD14+ cells 
The BM-MNC fractions from donor 1, 2 and 3 were depleted of CD14+ cells using the MACS 
cell separation system. When these cells were cultured after depletion of the CD14+ cells, 
small round adherent cells were observed during the first week of culturing (figure 3-1), and 
only few small adherent fibroblast-like cells were observed  during the second week.  
 
 
Figure 3-1. Before plating, CD14+ cells were 
depleted with the MACS system. A representative 
picture is shown for cells from donor 1 at day 6 in 
culture. Image magnified 200X. 
 
The BM MNC fractions from donor 4, 5 and 6 were established directly in culture without 
depletion of CD14+ cells. In these cultures, adherent fibroblast-like cells were observed from 
day 1, and between day 8 and 12 the cells reached 40% to 50 % confluence, and were ready to 
be replated. Only minor contaminations of monocytes were observed by a visual assessment 
of the cell cultures using a light microscope. After replating of the cells, no distinct monocyte 
contamination was observed  in the cultures (figure 3-2). However, visual assessment using a 
light microscope is a rough method for determining the purity of the cell cultures.   
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Figure 3-2. Images of cells expanded in 6% O2 and 5% CO2 (donor 6). (A) Cells at passage 0, containing 
monocytes that have a characteristic shape resembling “fried eggs”. (B)  For cells at passage 1, no distinct 
monocyte contamination was observed, and the hBM-MSC were larger. The morphology of the cells did not 
change during passage 1, 2 or 3. Images magnified 200X. 
 
Since the isolation procedure was efficient without depleting CD14+ cells, the hBM-MSC 
from donor 4, 5 and 6 were used for further experiments. 
3.2 Morphology of hBM-MSC 
From the first colony formation until the expansion was ended, the hBM-MSC showed the 
fibroblast-like shape displayed in figure 3-2. No marked alterations in cell morphology (size 
and shape) were observed between hBM-MSC expanded in the different gas tensions. 
However, for all gas tensions, the hBM-MSC appeared to be larger and longer in passage 1 to 
3 compared to passage 0 (figure 3-2). Although, not clear in the displayed images, a 
heterogeneous mix of cells was observed in all cell cultures. The majority of the cells 
appeared thin and spindle shaped, while a minor portion of the cells had a wider cell body 
containing a more flattened cytoplasm. 
3.3 Proliferation capability of hBM-MSC 
In order to compare the effect of different gas tensions on the proliferative capability of hBM-
MSC, the cells were counted at every passage and plated at a constant density of 3000 
cells/cm2. Growth curves showing the calculated cumulative cell counts between cells 
expanded in the different gas tensions are shown for donor 4 in figure 3-3.  
 




Figure 3-3. Proliferation rates of hBM-MSC (donor 4). hBM-MSC were plated in 175 cm2 flasks in culture 
medium at 3000 cells/cm2 and expanded in the O2 and CO2 tensions indicated for up to 23 days. At day 12, the 
cells were 40% to 50% confluent and were ready to be replated. Hence, the first cell count was performed at day 
12. 
 
All donors showed a similar growth pattern, and, the growth curve for donor 4 was therefore 
considered representative for the three donors. There were no consistent differences in cell 
counts between hBM-MSC expanded in the different gas tensions. 
3.4 Real-time RT PCR 
3.4.1 RNA purity and integrity  
All RNA samples (isolated from cells at passage 2) were checked for purity and integrity 
before real-time RT PCR. Table 3-1 shows the results from donor 4, and is representative for 
donor 5 and 6. 
 
Table 3-1. RNA concentration and OD260/OD280 .  
 
Donor 4 ng/ul OD260/OD280 
20% O2, 5% CO2 251.34 2.01 
20% O2, 7.5% CO2 218.49 2.02 
6% O2, 5% CO2 215.12 2.06 
6% O2, 7.5% CO2 225.05 2.09 
9% O2, 5% CO2 302.32 2.01 
9% O2, 7.5% CO2 241.09 2.05 
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All samples had an OD260/OD280 ratio of ~ 2.0, thereby indicating pure RNA, and that the 
samples could be used as templates for real-time RT PCR experiment. The integrity of the 
RNA samples was furthermore analyzed by agarose gel electrophoresis (figure 3-4).
  
 
Figure 3-4. 0.5-0.7 µg RNA were run on a 1% denaturing agarose gel in the presence of ethidium bromide. 
Image is from donor 4, and is representative for donor 5 and 6. 
 
Clear bands, without any smear, corresponding to 28S rRNA and 18S rRNA were observed, 
indicating that the RNA had not been subjected to degradation. 
 
3.4.2 Efficiency of RT 
In order to determine an appropriate amount of RNA input for the real-time RT PCR 
reactions, the efficiency of the RT reactions using various dilutions of RNA, ranging from 0.9 




Figure 3-5. A 2-fold dilution series of RNA were made. The real-time RT PCR reactions were set up using 
cDNA derived from the diluted RNA samples. Data are displayed as mean (n = 3). Standard deviation was too 
small to be visible in this plot.  
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The plot gave a linear curve, showing that the cDNA amounts produced were proportional 
with the amount of RNA input for all dilutions. This experiment demonstrated that all RNA 
inputs were suitable for real-time RT PCR. Of these concentrations, RNA amounts 
corresponding to 6 ng was chosen to be used in real-time RT PCR reactions. 
 
3.4.3 Validation of GAPDH as internal reference gene 
For valid determination of the gene expression levels measured by real-time RT PCR, the 
expression level of the gene used as an internal reference in the experiments can not be 
affected by the experimental treatment. Different gas tensions are known to alter the 
expression levels of many genes, including several standard housekeeping genes, such as 
GAPDH, which are frequently used as internal reference genes in real-time RT PCR122. In 
order to investigate if the different gas tensions affected the GAPDH levels in the cells, the 
amounts of GAPDH from cells expanded in the different gas tensions were determined by 
real-time RT PCR. The relative amounts are presented using the 2-∆C’t method in figure 3-6.  
 
Figure 3-6. Validation of GAPDH as internal control. mRNA levels were scaled according to “20% O2, 5% 
CO2”. This value was set to 1.Data are displayed as mean ± SD (n = 3). RNA input corresponding to 6 
ng/replicate was used for external normalization. A two sample t-Test was used to test for significant changes in 
mRNA levels. P ≤ 0.05 was considered significant.  
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There was no significant relationship between the gas tensions and the expression of GAPDH, 
indicating that the GAPDH levels in the cells were not affected by exposure to different gas 
tensions, and that the GAPDH expression level in the cells can be used as an internal 
reference for normalization of target genes measured by real-time RT PCR experiments.  
 
3.4.4 Amplification efficiency of gene expression assays 
Valid use of the 2 -∆∆Ct calculation requires that the PCR efficiencies of the target and 
reference amplicons are approximately equal120. To determine if the amplification efficiency 
of the OCT-4, KLF4, C-MYC, NANOG, and SOX2 assays were similar to the GAPDH assay, a 
3-fold dilution series of ECC derived RNA was made, and each of the five targets were 
amplified simultaneously with GAPDH. The ∆CT value was calculated for every dilution, and 














Figure 3-7. Relative efficiency plots of (A) OCT-4, (B) KLF4, (C) C-MYC, (D) NANOG and (E) SOX2. cDNA 
was synthesized from different amounts of RNA. RNA amount ranged from  0,025 ng RNA to 6 ng RNA. The 
amplification efficiency was examined using real-time RT PCR. Data are displayed as mean ± SD (n = 3)  
 
The slope of the curves between GAPDH and OCT-4, GAPDH and NANOG, GAPDH and 
KLF4, and GAPDH and C-MYC was between 0.1 and -0.1. This result shows that the PCR 
efficiency of these assays was similar, and that these assays could be used in real-time RT 
PCR. The slope of the curve between GAPDH and SOX2 was -0.29, demonstrating that the 
amplification efficiency of the two was not equal. Therefore, the SOX2 assay was excluded 
from the experiment. 
 
 
3.4.5 Expression of markers associated with primitive stem cell state 
In order to assess whether the gas tension used for hBM-MSC culture affected expression of 
primitive stem cell markers, real-time RT PCR analyses were performed on cells at passage 2. 
The relative amount of OCT-4, KLF4, C-MYC and NANOG mRNA is presented using the 2-
∆∆Ct
 method in figure 3-8.  
 












Figure 3-8. Relative expression was determined using real-time RT PCR. (A) Relative expression of OCT-4. (B) 
Relative expression of KLF4. (C) Relative expression of C-MYC. (D) Relative expression of NANOG. mRNA 
levels were scaled according to “20% O2, 5% CO2”. This value was set to 1 (calibrator).  Data are displayed as 
mean ± SD (n = 3). A two sample t-Test was used to test for significant changes in mRNA levels. Bonferroni 
corrections were applied to all experiments and P ≤ 0.05 was considered significant. * = P ≤ 0.05. 
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There was very little change in mRNA levels when scaled according to “20% O2, 5% CO2” 
(calibrator). However, some of the expression levels were statistically significant: 
 
OCT-4 
In donor 4 only one gas tension resulted in significant change in mRNA levels; hBM-MSC 
grown in “9% O2, 5% CO2” showed an increase in OCT-4 expression. hBM-MSC from donor 
5 had lower OCT-4 mRNA levels in all gas tensions compared to the calibrator. In donor 6 
up-regulation of OCT-4 was found in hBM-MSC expanded in “20% O2, 7.5% CO2” and “6% 
O2, 5% CO2”. 
 
KLF4 
hBM-MSC from donor 4 showed down-regulation of KLF4 when expanded in “20% O2, 
7.5% CO2” and up-regulation when expanded in the other gas tensions.  In donor 5 the 
calibrator had the highest level of KLF4 mRNA. hBM-MSC from donor 6 showed the same 




The C-MYC mRNA level in hBM-MSC from donor 4, expanded in “20% O2, 7.5% CO2” and 
“9% O2, 5% CO2”  was reduced, while it was increased in “6% O2, 5% CO2” and “6% O2, 
7.5% CO2”. In donor 5, all gas tensions resulted in downregulation, except for “9% O2, 7.5% 
CO2” which was not statistically different from the calibrator. hBM-MSC in all gas tensions, 




The NANOG expression level in cells from donor 4 expanded in “9% O2, 5% CO2” was 
significantly increased, while the expression levels in cells grown at other gas tensions were 
similar to the calibrator. The calibrator had the highest expression of NANOG in donor 5. In 
donor 6, hBM-MSC expanded in “6% O2, 5% CO2” and “9% O2, 5% CO2” had elevated 
amounts of NANOG, while hBM-MSC in “6% O2, 7.5% CO2” had lower amounts. 
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Only down-regulation of KLF4 in hBM-MSC grown in “20% O2, 7.5% CO2” were observed 
in cells from all three donors. Otherwise, there was no clear relationship between changed 
gene expression and gas tensions when comparing the three donors. All the statistically 
significant changes in gene expression levels detected in cells from donor 5 were reduced, 
while donor 4 and 6 had both reduced and increased expression levels compared to the 
calibrator.  
3.5 Microarray  
3.5.1 RNA integrity 
Before analysis, using the Illumina bead system, the integrity of the RNA samples was 
checked before and after amplification of the RNA. The gel like image in figure 3-9 showed 




Figure 3-9. No RNA degradation could be observed in any of the samples before amplification of the RNA. 
Degradation would be reflected by smearing of the bands. D4 = Donor 4, D5 = Donor 5, D6 = Donor 6. 
 
All samples had a RIN value of 10 (data not shown), which indicate intact RNA. Further, the 
amplified biotin labeled mRNA was not degraded (data not shown). 
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3.5.2 Clustering and pairwise comparisons 
Service XS in Leiden performed chip quality analysis. All chips were of high quality (data not 
shown). However, hierarchical clustering (condition three) in Genespring was applied in order 
to see if there were any outliers among the samples. The condition three grouped the samples 
from the same donor into separate sub clusters, except for “Donor 5, 6% O2, 7.5% CO2”, 
which had its own branch (figure 3-10).  
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Figure 3-10. Samples were grouped together based on similar expression profiles. Each gene has been assigned 
a color based on the signal intensity. Yellow = normal expression, red = high expression, blue = low expression.  
 
Generally, in this kind of experiments, samples that do not belong in any subcluster are 
potential outliers. In the condition three in figure 3-10, all pair of clusters had a correlation 
higher than 94% (including the correlation between “Donor 5, 6% O2, 7.5% CO2” and the rest 
of the samples), indicating no significant technical variation between the samples . Therefore, 
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no samples were removed from the experiment. In order to obtain a rough overview over the 
differently expressed genes, the different gas tensions were compared using scatterplots with 
2-fold as cut-off value. A scatterplot comparing “20% O2, 5% CO2” with “6% O2, 7.5% CO2” 




This scatterplot shows a pairwise comparison between “20% O2, 5% CO2” and “6% O2, 7.5% CO2. The X and Y 
axes represent the expression levels in the two samples. For each gene on the beadchip, a single dot is placed at 
the intersection of these two values. All 46718 probes are represented in this plot. The two outer lines indicate a 
2-fold difference, whereas the central line represents equality. 
 
Out of the 46718 genes (probes) represented on the beadchip, 44 genes were differently 
expressed (>2-fold) between “20% O2, 5% CO2” and “6% O2, 7.5% CO2”. For the 
comparisons between “20% O2, 5% CO2” and “9% O2, 5% CO2”, and “6% O2, 7.5% CO2” 
and “9% O2, 5% CO2”, 1 and 42 genes, respectively, were found to be differently expressed 
(>2-fold). In summary, these results show that few genes were differently expressed between 
hBM-MSC expanded in the different gas tensions.    
 
3.5.3 Data analysis   
In order to exclude data that are unlikely to be of biological interest, a quality control on the 
genes was applied. First, genes that showed large variability in gene expression were 
removed. Subsequently, genes with less than 1.5-fold change difference across the experiment 
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were excluded. The quality control reduced the number of genes from 46718 genes to 492 
genes. This gene list was analyzed by one-way ANOVA, with 0.05 as false discovery rate. 
First, multiple testing correction was omitted. This resulted in 58 genes that were found to be 
differently expressed between the different gas tensions. Subsequently, pairwise comparisons 
between the different gas tensions were performed using volcano plots. A volcano plot 
comparing “20% O2, 5% CO2” with “6% O2, 7.5% CO2” is shown in figure 3-12. 
 
 
Figure 3-12. In this volcano plot, the size of the fold change between “20% O2, 5% CO2” and “6% O2, 7.5% 
CO2”, is compared to the statistical significance level. The horizontal axis is the fold change between the two 
groups (on a log scale, so that up- and down-regulation appear symmetric). The vertical axis represents the p-
value for a t-test of differences between samples. Each spot represent one gene. Genes with negative values on 
the x-axis represent genes that are up-regulated in “6% O2, 7.5% CO2” compared to “20% O2, 5% CO2”. Genes 
with positive values on the x-axis represent genes that are up-regulated in “20% O2, 5% CO2” compared to “6% 
O2, 7.5% CO2”. Equality is represented by 0. The two green vertical lines represent a 2-fold cut-off, and the 
green horizontal line represents a P-value of 0.05. The red spots represent genes that passed the restrictions.  
 
 
In figure 3-11, eight genes were up-regulated in “6% O2, 7.5% CO2”, while 2 genes were up-
regulated in “20% O2, 5% CO2”. Volcano plots were made for all comparisons. The genes 
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Table 3-4. Genes up-regulated in “6% O2, 7.5% CO2” compared to “20% O2, 5% CO2”. 
 
 
Table 3-5. Genes up-regulated in “6% O2, 7.5% CO2” compared to “9% O2, 5% CO2”. 
 
No genes were found to be up-regulated in “9% O2, 5% CO2” compared to the two other gas 
tensions. 
 
However, when omitting the multiple testing correction in the one-way ANOVA analysis, 25 
of the 58 genes were expected to pass by chance (false positives). Almost half of the genes 
(42.4%) that passed the one-way ANOVA analysis can therefore be expected to be false 
positives. Thus, the gene lists in table 3-2, 3-3, 3-4, and 3-5 most likely contain many false 
positives. To reduce the number of false positives, the Benjamini and Hochberg multiple 
testing correction was applied in the one-way ANOVA. This restriction resulted in no 
significant change in gene expression between the different gas tensions.   
 
 
Gene Name GenBank accession no. Fold change 
Slit homolog 3 (Drosophila) (SLIT3) NM_003062 2,067 
Growth differentiation factor 5 (cartilage-derived morphogenetic protein-1) (GDF5) NM_000557 2,051 
Gene Name GenBank accession no. Fold change 
Caldesmon 1 (CALD1) NM_033138 2,035 
Gene Name GenBank accession no. Fold change 
Prostaglandin E synthase (PTGES) NM_004878 2,617 
Protein tyrosine phosphatase, receptor type, B (PTPRB) NM_002837 2,544 
Serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 (SERPING1) NM_000062 2,481 
Zinc finger protein 185 (LIM domain) (ZNF185) NM_007150 2,353 
Insulin-like growth factor binding protein 3 (IGFBP3) NM_001013398 2,137 
Amyloid beta (A4) precursor protein-binding, family B (APBB1IP) NM_019043 2,062 
Sperm associated antigen 4 (SPAG4) NM_003116 2,029 
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4) NM_004567 2,016 
Gene Name GenBank accession no. Fold change 
Insulin-like growth factor binding protein 3 (IGFBP3) NM_001013398 3,128 
Prostaglandin E synthase (PTGES) NM_004878 2,597 
Serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 (SERPING1) NM_000062 2,516 
Fibronectin type III domain containing 1 (FNDC1) NM_032532 2,433 
Protein tyrosine phosphatase, receptor type, B (PTPRB) NM_002837 2,167 
Periostin, osteoblast specific factor (POSTN) NM_006475 2,145 
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4. Discussion 
Standard incubator gas tensions corresponding to 20% O2, and 5% CO2 are routinely used for 
in vitro expansion of hBM-MSC, and it is being overlooked that such conditions do not 
correspond to the physiological gas tensions found in the bone marrow microenvironment. 
Therefore, the role of gas tensions in the expansion of hBM-MSC is not understood. As gas 
tension is an important component of the hBM-MSC niche, it may take part in the regulation 
of self-renewal and differentiation of hBM-MSC. In order to investigate the in vitro effects of 
different incubator gas tensions, hBM-MSC were cultured in six different gas tensions. 
Growth curves were made to assess the proliferative capability of the cells, real-time RT PCR 
analysis and microarray analysis was used to assess differences in gene expression.  
 
FBS is generally used as nutritional supplement for in vitro expansion of hBM-MSC. 
However, in this thesis, AS was used as nutritional supplement. In order to reduce monocyte 
contamination, monocytes are frequently depleted from the BM-MNC fraction before 
culturing the cells. Observations have indicated reduced monocyte contamination when 
culturing hBM-MSC in AS (non-published data from Dr. Brinchmann’s laboratory). 
Therefore, this study also aimed at examining if depletion of monocytes was necessary when 
using AS as nutritional supplement. 
4.1 Choice of serum supplement 
Serum is the clear liquid part of blood that remains after blood cells and clotting factors have 
been removed. The exact composition of serum is unknown, but it supplies the culture 
medium with essential cytokines, growth factors, antioxidants, fatty acids, hormones, and 
proteins that cells require during culture. In vitro hBM-MSC are expanded in culture medium 
containing 10% to 20 % serum, and until recently, FBS was the only serum choice. If hBM-
MSC is to be used in cellular therapy, all animal-derived products should ideally be excluded 
because of possible contamination by prions, viruses or zoonoses infections127. Other 
problems concerning the use of FBS are immune reactions to fractions of bovine proteins, 
which may lead to antibody formation128 and rejection of the transplanted cells. The use of 
serum supplements other than FBS is therefore desirable. Recently, AS and allogeneic human 
serum (alloHS) were examined to see if they could replace FBS for in vitro expansion of 
hBM-MSC. AS was shown to be as good as, or better than FBS, but the use of alloHS 
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resulted in growth arrest and cell death24. The use of AS could eliminate, or reduce the risk of 
contamination that follows the use of FBS. Hence, it may be the preferable choice of serum 
supplement for in vitro expansion of hBM-MSC for cellular therapy. Based on this, it was 
decided to use AS as serum supplement in this thesis. One potential limitation is the amount 
of AS needed to expand hBM-MSC on a clinical scale. AS is prepared from venous blood, 
and the maximum amount of venous blood that can be drained is 450 ml, which yields 
approximately 200 ml of AS. This amount is sufficient for expansion of hBM-MSC, derived 
from 60-80 ml bone marrow aspirate, to a total number between 50-80 millions. However, the 
total number of hBM-MSC will depend on the isolation procedure, culture method, amount of 
bone marrow aspirate, and the proliferation capability of the cells.   
4.2 Cells 
Established cell lines are often used for in vitro experiments, and since these cells often have 
been expanded in culture for a long time, they have to some extent adapted to life in culture. 
One the other hand, cells that are freshly isolated from the body are certainly not adapted to 
the same in vitro conditions. These cells may display characteristics that more resemble their 
in vivo properties, but at the same time they do not exhibit their true in vivo properties. In 
addition, donor specific differences are expected to be more distinct between freshly isolated 
cells compared to that of established cell lines. Ideally, if hBM-MSC are to be used in cell 
therapy, the patients own cells should be used. Therefore, freshly isolated hBM-MSC from 
the bone marrow were used in this thesis. 
4.3 Monocyte depletion 
Isolation of hBM-MSC is based on their ability to adhere to the culture substrate. However, 
this method often results in monocyte contamination. When expanding hBM-MSC in medium 
supplemented with FBS, depletion of monocytes seems to be necessary. Otherwise the culture 
substrate is largely occupied by contaminating monocytes. Previous observations indicate that 
monocyte contamination is significantly reduced when AS is used as serum supplement (non 
published data from Dr. Brinchmann’s laboratory). Therefore, it was decided to test if 
depletion of monocytes were necessary when culturing hBM-MSC in AS. Monocytes can be 
depleted from the BM-MNC fration based on their expression of the CD14 molecule (section 
2.4.2). According to observations in the light microscope, monocytes were not a significant 
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source of contamination in the cultures used in this study, and no distinct monocyte 
contamination was observed after the first passaging of the cells. This experiment indicate 
that monocyte depletion is unnecessary when expanding the cells in culture medium 
supplemented with AS. The factors responsible for this difference are unknown and remain to 
be identified. Another interesting observation was that depletion of monocytes resulted in 
poor yield of hBM-MSC colonies. What caused this difference in colony formation is 
unknown. A possible explanation may be unspecific binding of the CD14 antibodies during 
the cell separation procedure. As the aim of this experiment only was to test the necessity of 
depleting CD14+ monocytes, no further investigation was pursued to identify the factors 
responsible for these differences. 
4.4 Morphology 
As observed in the light microscope, most hBM-MSC were thin and spindle shaped. 
However, a small portion of the cells were wide with a more flattened cytoplasmic volume. 
Under current in vitro culture condition, hBM-MSC can be expanded for 30-40 population 
doublings before they enter replicative senescence, which is characterized by growth arrest, 
and eventually cell death129. During cell division, the DNA polymerase is not able to replicate 
the end of the telomeres (the tip of linear chromosomes)130, 131. Hence, for every cell division 
the chromosomes become shorter. When the telomeres reach a critical length, the cells enter 
replicative senescence. Thus, there is a limit for how many cell divisions the hBM-MSC can 
go through. In the case of hBM-MSC, they become wide with a flattened cytoplasm when 
entering replicative senescence. Hence, the large, and wide hBM-MSC observed in the 
cultures had most likely gone through several cell divisions before they were isolated from the 
bone marrow. Therefore, it is likely that these cells were close to, or had entered replicative 
senescence.     
4.5 Cell counts 
In order to assess the proliferative capability of the cells, growth curves were made for all gas 
tensions. According to the growth curves, there were no consistent differences in cell counts 
between hBM-MSC expanded in 20%, 6% and 9% O2 with both 5% and 7.5% CO2 (figure 3-
3). The small differences shown in figure 3-3 can be expected due to uncertainty in the 
counting procedure. Cell counts from donor 5 and 6 showed the same pattern as donor 4. 
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Hence, in the culture system used in this thesis, O2 and CO2 tension did not seem to affect the 
proliferation capability of polyclonal hBM-MSC.  
4.6 RNA quality 
mRNA is the starting material for real-time RT PCR and microarray analysis. The mRNA is 
always reverse transcribed into cDNA that can be used further in real-time RT PCR and 
microarray. To be of relevance, the amount of cDNA generated by the RT has to be 
proportional to the relative amount of its RNA template121. Thus, a prerequisite is that the 
mRNA is intact. Otherwise the RT reactions would yield varying amounts of cDNA. 
However, RNA is labile and susceptible to degradation. Therefore, it is always recommended 
to validate the RNA integrity before starting the RT reaction. Because real-time RT-PCR and 
microarray analysis was performed in two different laboratories in this thesis, RNA integrity 
was validated by two independent methods. The first method was based on separation of the 
RNA on an agarose gel. The second method was validation by the Agilent Bioanalyzer 
system. Both methods demonstrated high RNA integrity (figure 3-4 and 3-9), ensuring a good 
starting point for gene expression analysis.  
4.7 Real-time RT PCR 
4.7.1 Choice of targets and optimalisation 
Verfaillie et al. induced expression of OCT-4 by culturing MAPC clones in 5% O2116. OCT-4 
is one of the major genes that are known to regulate self-renewal and differentiation of ESC. 
It was therefore interesting to examine if OCT-4 mRNA levels changed during expansion of 
polyclonal hBM-MSC in different O2 levels. Therefore, OCT-4 was chosen as target for real-
time RT PCR. Other genes associated with pluripotent stem cells were also investigated. 
NANOG is a transcription factor that is well known to regulate self-renewal and 
differentiation in ESC.132, 10. Thus, NANOG mRNA levels were also subjected to real-time RT 
PCR. Takahashi et.al induced pluripotent stem cells from mouse embryonic, and adult 
fibroblast by introducing OCT-4, SOX2, KLF4 and C-MYC into the cells. All four genes was 
required to maintain the pluripotent properties of the cells13. Therefore SOX2, KLF4, and C-
MYC mRNA levels were also used as targets in the real-time RT PCR. However, before 
quantifying the relative changes in mRNA levels of the selected genes, certain assumptions, 
and the testing of these assumptions were performed to properly analyze the data. In 
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summary, the important steps in the design of a real-time RT PCR experiment is to121, 120: (i) 
find proper amount of RNA input that will be efficiently reverse transcribed to cDNA, (ii) 
select an internal reference, and (iii) validate the internal reference to determine that it is not 
affected by experimental treatment. The last step is to determine the amplification efficiencies 
of the target and internal reference to ensure that the efficiency amplicons are similar.  
 
Amplification of cDNA derived from different amounts of RNA was performed to assess the 
efficiency of the RT reaction (section 2.8.2). As demonstrated by the linear curve in figure 3-
5, cDNA amounts produced were proportional with the amount of RNA input for all dilutions. 
Therefore, all RNA amounts were suitable. In order to determine if the internal reference 
(GAPDH) was affected by the different gas tensions, cDNA derived from hBM-MSC 
expanded in the different gas tensions were amplified by real-time RT PCR (section 2.8.3). In 
this experiment only one target was amplified. Therefore, an external normalisation had to be 
used120. A fixed amount of RNA (corresponding to 6 ng RNA/replicate) was used as the 
external normalisation. There was no relationship between the gas tensions and the expression 
of GAPDH, as shown in figure 3-6. Therefore, GAPDH was a suitable internal control for this 
gene expression experiment. Furthermore, the amplification efficiency of the targets and the 
internal reference was assessed by looking at how ∆CT varied with template dilution (section 
2.8.4). The OCT-4, NANOG, KLF4 and C-MYC assays had amplification efficiencies similar 
to that of GAPDH, and were therefore suitable for relative quantification using real-time RT 
PCR. The curve obtained after comparing the GAPDH and SOX2 assays, had a slope of -0.29, 
showing that the amplification efficiency of the two was not similar (figure 3-7). Thus, the 
SOX2 assay was not suitable for RQ using real-time RT PCR, and was therefore excluded 
from the experiment. If SOX2 had been very important for us, the analysis could be performed 
via the absolute quantification method using standard curves. Alternatively, new primers 
could be used.  
 
4.7.2 Relative quantification 
For the relative quantification analysis, all mRNA levels were scaled according to standard 
incubator gas tension (20% O2, 5% CO2). Only small fold changes were detected, below two-
fold for most comparisons. A two-fold change can be at the limit of detection of real-time RT 
PCR133. Small fluctuations in the starting material will lead to relatively high fluctuations in 
the amount of product, which is expressed in CT values (a CT difference of one represents a 
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two-fold difference in starting material). Therefore, a two-fold difference in mRNA levels 
may be due to methodological variability. However, some of the fold changes were found to 
be statistically significant, but there was no consistent pattern regarding expression of OCT-4, 
NANOG, KLF4, and C-MYC in the different gas tensions (figure 3-8). Only reduced KLF4 
mRNA levels, in 20% O2 and 7.5% CO2, was shared between the three donors. Beyond that, 
the rest of the results were inconsistent. For example, in hBM-MSC from donor 4, there was a 
higher expression of OCT-4 in 9% O2 and 7.5% CO2 compared to the standard incubator gas 
tension. In the same comparison for donor 5, OCT-4 mRNA levels were found to be reduced. 
On the other hand, in donor 6, OCT-4 mRNA levels were not significantly changed. Due to 
the small fold changes, and the lack of consistent pattern in gene expression, gas tension did 
not seem to affect expression of markers associated with pluripotent stem cells. In addition, 
the fold changes that were found to be statistically significant were based on three technical 
replicates (replicates from same donor and same gas tension). Technical replicates reduce the 
effects of variation introduced by the technology used, but it does not reduce the effects of 
biological variation (donor specific differences). If the results from the three donors had been 
used as biological replicates (that is, replicates consist of samples from different donors, but 
from the same gas tension), the effects of biological variation would have been reduced. As a 
result, the fold change differences would most likely have been reduced and fewer 
measurements would have been significant.  
4.8 Microarray 
Due to economical issues, only “20% O2, 5% CO2”, “6% O2, 7.5% CO2”, and “9% O2, 5% 
CO2” were analyzed by microarray. After discussing the experimental design with the 
Microarray core facility at Rikshospitalet-Radiumhospitalet, it was decided to use samples 
from the same gas tension (different donors) as biological replicates. Service XS in Leiden, 
the Netherlands, performed beadchip quality analysis, and confirmed that the beadchips was 
of high quality. After receiving the data files, they were imported into Genespring GX 7.3.1 
for analysis (section 2.9.2). As a quality control on the samples, a hierarchical clustering 
(condition three) was performed. The condition three clustered the samples into 3 subclusters, 
and one branch. The subclusters consisted of samples derived from the same donor. For donor 
5, two of the samples were grouped together, while “Donor 5, 6% O2, 7.5% CO2” had its own 
branch (figure 3-10). Because “Donor 5, 6% O2, 7.5% CO2” was placed alone in the condition 
three, it was a potential outlier. However, the correlation between “Donor 5, 6% O2, 7.5% 
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CO2” and the rest of the samples was higher than 94% (this was true for all pair of clusters). 
The correlation is related to the technical variation that can be introduced during the 
microarray procedure. A correlation higher than 90% is considered high, with little technical 
variation between samples, while 70-75% correlation is the absolute minimum criterion. 
Therefore, “Donor 5, 6% O2, 7.5% CO2” was not considered an outlier. Before starting the 
thoroughly analysis, the differences in gene expression were roughly assessed using pairwise 
comparisons (scatterplots) of the different gas tensions (figure 3-11). With a two-fold cut-off, 
44 of the 46718 genes in the beadchip were differently expressed when comparing “20% O2, 
5% CO2” and “6% O2, 7.5% CO2”. Comparison between “20% O2, 5% CO2” and “9% O2, 5% 
CO2”, showed only 1 gene with changed expression. The last comparison between “6% O2, 
7.5% CO2” and ”9% O2, 5% CO2” resulted in 42 differently expressed genes.    
 
The beadchip that was used to obtain the data files contained probes for many genes that were 
either not expressed, expressed only in a few samples, or expressed at relatively constant 
levels. It is always a good strategy to remove these genes prior to performing other operations. 
Therefore, a quality control on the genes was performed. To do this, genes with high 
variability around the mean, and genes whose expression did not change more than 1.5-fold, 
between the different gas tensions, were removed from the data set. The resulting gene list 
was then reduced from 46718 genes to 492 genes. To obtain genes with statistical 
significance, a one-way ANOVA was applied on the 492 genes. Without multiple testing 
correction, 58 genes were found to be differently expressed between the different gas 
tensions. With a false discovery rate of 5%, 25 genes were expected to pass the one-way 
ANOVA restriction by chance (false positives). However, pairwise comparisons between the 
different gas tensions were performed using volcano plots (figure 3-12). Gene lists in table 3-
2, 3-3, 3-4, and 3-5 show the genes that passed the volcano plot restrictions. 
 
Although the gene lists obtained could contain false positives, it was still decided to determine 
the possible biological relevance of differential expression of these genes. For example, 
Growth differentiation factor 5 (GDF5), which was up-regulated in “20% O2, 5% CO2” 
compared to “6% O2, 7.5% CO2”, is a member of the BMP family and the TGF-β 
superfamily134. The members of this family are regulators of cell growth and differentiation, 
and have been showed to regulate chondrogensis79, 80, 135. GDF5 is also involved in nervous 
system development, according to the gene ontology in Genespring (data not shown). 
Prostaglandin E synthase (PTGES), 6-phosphofructo-2kinase/fructose-2,6-bisphosphatase 4 
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(PFKFB4), and Insulin-like growth factor binding protein 3 (IGFBP3) were among the genes 
that were up-regulated in “6% O2, 7.5% CO2”, when compared to “20% O2, 5% CO2”. 
PTGES and PFKFB4 have been shown to be up-regulated in rBM-MSC when cultured in low 
O2 tension (1%)136. PTGES is an enzyme which is induced by proinflammatory stimuli, and is 
down-regulated by anti-inflammatory glucocorticoids137. PFKFB4 is an activator of 
glycolysis, and are known to be induced by low O2 tensions138, 139. According to gene 
ontology in Genespring, IGFBP3 are involved in skeletal muscle development (data not 
shown), and have also been shown to be up-regulated in low O2 tensions (2% O2)140. PTGES 
and IGFBP3 were also up-regulated in “6% O2, 7.5% CO2“, when compared to “9% O2, 5% 
CO2”. Although statistical considerations suggest that these genes may be falsely represented 
on the list of differentially expressed genes, the fact that they have been shown to be induced 
by low O2 tensions in other datasets may indicate that the upregulation of these genes in “6% 
O2, 7.5% CO2“ may actually be real. No genes were found up-regulated in “9% O2, 5% CO2” 
compared to the two other gas tensions. Although these findings were interesting, it is 
important to emphasize that almost half of the genes that passed the one-way ANOVA 
analysis were expected to pass by chance. On the other hand, it should not be completely 
ruled out that a few of the genes may be significant, but the results should be interpreted with 
great caution. Many researchers choose real-time RT PCR as a supporting technique to 
validate and better quantify the most interesting genes from their arrays. However, it was 
decided not to do this, because no genes were found differently expressed when applying 
multiple correction in the one-way ANOVA analysis (see below). In addition, the lower the 
fold change differences, the less correlation is seen between real-time RT PCR and 
microarray results, making the validation less reliable141. The low fold change differences in 
this experiment may be at the boundary where microarray and real-time RT PCR data begin to 
lose correlation. 
 
To reduce the number of false positives, in order to obtain more reliable data, the one-way 
ANOVA analysis was repeated using multiple testing correction (Benjamini and Hochberg). 
This resulted in no differently expressed genes between the different gas tensions. Thus, the 
main conclusion of the microarray analysis is that gas tension did not affect the global gene 
expression of polyclonal hBM-MSC. It is worth mentioning that the data files also were 
analyzed in another analysis platform (Bioconductor) (by another independent investigator -
Morten Mattingsdal from the Microarray core facility at Rikshospitalet-Radiumhospitalet). As 
in Genspring, no genes were found differently expressed when analyzing the data in 
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Bioconductor. This confirmed the results, and thereby strengthened the conclusion that gas 
tension did not affect the global gene expression in the cells. Microarray was performed on 
hBM-MSC expanded in three of the six different gas tensions. However, it is reasonable to 
assume that the results were representative for hBM-MSC expanded in all gas tensions. 
 
Taking together the data from the growth curves, the real-time RT PCR, and the microarray 
analysis, all results indicate that the different incubator gas tension used in this thesis do not 
have an effect on the in vitro expansion of polyclonal hBM-MSC.  
4.9 Considerations 
Verfaillie et al. cultured rat MAPC at very low cell density (300 cell/cm2), and in a serum 
concentration of 2%116. Maybe there would be a difference in gene expression if the same 
conditions had been used in this study. However, the effect of serum concentration of 2% 
needs to be examined with hBM-MSC, before such studies can be performed. In addition, if 
hBM-MSC are to be used in cell therapy, huge amounts of cells is required. By plating cells 
on densities corresponding to 300 cells/cm2, the culture surface needed would be enormous. 
In the laboratory used during this thesis, it is practically impossible to expand the cells to 
quantities required for cell therapy, at such low cell densities. Thus, the culture system used in 
this thesis was the most suitable for this study.  
 
Recently, several studies have investigated the effects of low O2 tensions on MSC with 
contrasting results. For example, hBM-MSC expanded in 2% O2, increased proliferation and 
expressed higher levels of OCT-4142. Another study where hBM-MSC were expanded in 1.5% 
O2, also showed an increase in proliferation. In addition, 45 genes were reported to be up-
regulated, and several of the genes were known to be regulated by O2 tension110. rBM-MSC 
enhanced transcription of genes involved in cell proliferation and survival when cultured in 
1% O2136. Another study with rBM-MSC increased proliferation and enhanced osteoblast 
differentiation when grown in 5% O2112. On the other hand, murine adipose derived MSC 
(mAT-MSC) showed enhanced proliferation, but reduced osteogenesis and chondrogenesis in 
2% O2143. Human adipose derived MSC (hAT-MSC) lowered proliferation and enhanced their 
chondrogenic differentiation in 5% O2144. These conflicting data may be explained by 
different isolation methods, culture methods, type of culture (3D construct and monolayer), 
species differences, tissue of origin, and differences in O2 tension. Therefore, it is also 
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difficult to compare these results with the results obtained in this thesis. However, in most of 
these studies, the cells were cultured in 2% O2, or below. In such low O2 levels, the cells may 
switch from aerobe to anaerobe metabolism. This would for certain alter their gene 
expression. Hypoxia-Inducible Factor 1α (Hif-1α) is a transcription factor that has been 
shown to be expressed under such conditions145. The stability and activation of Hif-1α is 
highly regulated by O2 tension. The gene is constitutively expressed at the transcriptional 
level, but the protein is degraded when O2 levels exceed 2%145. Hif-1α controls expression of 
many genes. Some of them are involved in cellular differentiation, such as erythropoietin 
(EPO), transferrin, transferrin receptor, vascular endothelial growth factor (VEGF), platelet-
derived growth factor β (PDGF- β), and basic fibroblast growth factor (bFGF)146-149. In 
addition, Hif-activation results in increased expression of OCT-4150. Conversely, the 
differentiation gene PPAR-γ is down regulated as a result of Hif-activation151. In this thesis, 
hBM-MSC were not subjected for such low O2 tensions, because these O2 tensions are most 
likely below the physiological O2 tension in the bone marrow. This may explain why there 
were no differences in cell counts and gene expression in the cell cultures used in this thesis.  
During cell culture, trypsin was used to lift the cells from the culture surface. Hence, the cells 
were exposed to the gas tensions in the trypsin solution for approximately seven minutes, 
before the RNA isolation procedure. It is possible that this also affected the gene expression, 
and reduced possible differences.  
 
There is also a small possibility that some genes were regulated at the protein level. These 
genes would not be detected in this experiment, because the real-time RT PCR and microarray 
analysis quantified the mRNA levels in the cells. This is a major drawback with use of RNA 
analysis methods. The control of gene expression can occur at any step in the pathway from 
gene to functional protein152. Thus, gene expression may be regulated after synthesis of the 
mRNA molecules. For example, mRNA degradation, translation initiation, and protein 
processing and degradation are stages were cells can regulate their gene expression152. By 
using regulatory mechanisms that operate after transcription, cells can fine-tune gene 
expression in response to environmental changes without altering their transcription patterns. 
Therefore, real-time RT PCR and microarray analysis do not always reflect the real gene 
expression changes in cells. On the other hand, if a gene is found to be differently expressed 
by real-time RT PCR, or microarray, protein quantification methods can be a good strategy to 
validate that the gene is differently expressed at the protein level as well.  
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The previous studies, mentioned above, investigated the effects of low O2 tension on MSC, 
and compared with cells cultured at the traditional 20% O2 condition (hyperoxia)110, 136, 142-144. 
When hBM-MSC are expanded in hyperoxia, they are introduced to very high O2 levels that 
they never have experienced before. Depending on the experimental settings, it may be 
relevant to study the effects of hyperoxia, instead of the effects of low O2 tension. For 
example, do cells increase expression of OCT-4 when cultured in O2 tensions corresponding 
to normoxia, or is the expression reduced when the cells are introduced to hyperoxia? This 
may be a matter of terminology, but it is worth keeping in mind when performing experiments 
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5. Conclusion 
5.1 Depletion of CD14+ cells. 
• Monocytes were not a significant source of contamination when hBM-MSC were 
cultured in AS. Therefore, depletion of CD14+ cells seems to be unnecessary, prior to 
culture. 
• Depletion of CD14+ cells gave poor yield of hBM-MSC colonies 
 
What caused these differences is not known and remains to be identified. 
5.2 The in vitro effects of different incubator gas tensions on hBM-MSC. 
• Incubator gas tension did not seem to have an effect on the proliferative capability of 
the cells, as there were no consistent differences in cell counts between hBM-MSC 
expanded in the different gas tensions. 
• Results from real-time RT PCR analysis indicated that the expression of OCT-4, 
NANOG, KLF4, and C-MYC mRNA levels, were not affected by the different 
incubator gas tensions. 
• The global gene expression of hBM-MSC was not significantly changed due to the 
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